| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CD8 receptor binding | 6.15e-09 | 9 | 176 | 5 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 6.15e-09 | 9 | 176 | 5 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.22e-08 | 10 | 176 | 5 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.22e-08 | 10 | 176 | 5 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.22e-08 | 10 | 176 | 5 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 3.79e-08 | 12 | 176 | 5 | GO:0030881 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 7.63e-08 | 42 | 176 | 7 | GO:0071889 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 2.85e-07 | 17 | 176 | 5 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 7.00e-07 | 20 | 176 | 5 | GO:0042608 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 7.00e-07 | 20 | 176 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 4.40e-06 | 49 | 176 | 6 | GO:0042605 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 8.34e-06 | 32 | 176 | 5 | GO:0042288 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.52e-05 | 36 | 176 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 SH2D3C ARHGEF16 TBC1D9 TIAM1 RGPD3 ARHGAP25 HERC1 SIPA1L2 FGD6 ARHGAP21 RGPD5 | 4.51e-05 | 507 | 176 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 SH2D3C ARHGEF16 TBC1D9 TIAM1 RGPD3 ARHGAP25 HERC1 SIPA1L2 FGD6 ARHGAP21 RGPD5 | 4.51e-05 | 507 | 176 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 7.72e-05 | 50 | 176 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 9.28e-05 | 161 | 176 | 8 | GO:0051087 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.02e-04 | 53 | 176 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | receptor tyrosine kinase binding | 1.45e-04 | 90 | 176 | 6 | GO:0030971 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.58e-04 | 58 | 176 | 5 | GO:0042287 | |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 RGPD2 RANBP2 RGPD8 TBC1D9 RGPD3 ARHGAP25 SIPA1L2 ARHGAP21 RGPD5 | 1.91e-04 | 279 | 176 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 RGPD2 RANBP2 RGPD8 SPTBN1 KIF16B TRIOBP ARHGEF16 INF2 RGPD3 FGD6 | 3.64e-04 | 360 | 176 | 11 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 RGPD2 RANBP2 RGPD8 KIF16B TRIOBP ARHGEF16 INF2 RGPD3 FGD6 | 5.79e-04 | 321 | 176 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 9.07e-04 | 49 | 176 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | actin filament binding | 9.35e-04 | 227 | 176 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | SYNE1 INPPL1 SPTBN1 SPTBN2 TRIOBP ITPRID2 LDB3 INF2 MACF1 PRKN PLEC MYO15A | 1.15e-03 | 479 | 176 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | RGPD4 RGPD2 RANBP2 RGPD8 BIRC6 RSPRY1 FBXO9 RGPD3 IRF2BPL PRKN HERC1 FBXW7 | 2.00e-03 | 512 | 176 | 12 | GO:0019787 |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 2.09e-03 | 149 | 176 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 2.19e-03 | 103 | 176 | 5 | GO:0008276 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate binding | 2.52e-03 | 31 | 176 | 3 | GO:0080025 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | RGPD4 RGPD2 RANBP2 RGPD8 BIRC6 RSPRY1 FBXO9 RGPD3 IRF2BPL PRKN HERC1 FBXW7 | 2.74e-03 | 532 | 176 | 12 | GO:0016755 |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 5.22e-10 | 13 | 173 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 9.07e-10 | 14 | 173 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 2.15e-09 | 8 | 173 | 5 | GO:0002485 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.80e-09 | 9 | 173 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 9.54e-09 | 10 | 173 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.12e-08 | 20 | 173 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.59e-07 | 16 | 173 | 5 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 2.23e-07 | 17 | 173 | 5 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 2.23e-07 | 17 | 173 | 5 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 3.07e-07 | 18 | 173 | 5 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.07e-07 | 18 | 173 | 5 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.17e-06 | 23 | 173 | 5 | GO:0019885 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell cytokine production | 1.51e-06 | 11 | 173 | 4 | GO:0002729 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 1.68e-06 | 169 | 173 | 10 | GO:0010977 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 1.82e-06 | 25 | 173 | 5 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 1.82e-06 | 25 | 173 | 5 | GO:0002475 | |
| GeneOntologyBiologicalProcess | natural killer cell cytokine production | 2.25e-06 | 12 | 173 | 4 | GO:0002370 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell cytokine production | 2.25e-06 | 12 | 173 | 4 | GO:0002727 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway | 2.31e-06 | 4 | 173 | 3 | GO:0002488 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent | 2.31e-06 | 4 | 173 | 3 | GO:0002489 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 2.93e-06 | 48 | 173 | 6 | GO:0002478 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | 5.73e-06 | 5 | 173 | 3 | GO:0002481 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class Ib | 5.73e-06 | 5 | 173 | 3 | GO:0002477 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 6.57e-06 | 32 | 173 | 5 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 9.00e-06 | 58 | 173 | 6 | GO:0019884 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 CCDC14 RAB23 RGPD2 RANBP2 EMC1 WASHC2C RGPD8 DYNC2H1 FAM53A SYNE1 GRIK5 WASHC2A CHMP7 RGPD3 NUP133 WDR35 MACF1 DLG4 PRKN TIMM44 PACSIN2 RGPD5 FBXW7 | 1.46e-05 | 1091 | 173 | 24 | GO:0033365 |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.57e-05 | 38 | 173 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 1.77e-05 | 134 | 173 | 8 | GO:0010906 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 RAB23 RGPD2 RANBP2 WASHC2C RGPD8 DYNC2H1 FAM53A SYNE1 PPP1R12A KIF16B SIRT7 EIPR1 WASHC2A PLEKHM1 CHMP7 MDN1 STXBP3 RGPD3 SEC24B NUP133 WDR35 TMED9 PRKN TIMM44 ARHGAP21 DOP1B PCNT RGPD5 | 1.90e-05 | 1496 | 173 | 29 | GO:0046907 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 2.30e-05 | 41 | 173 | 5 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 2.59e-05 | 42 | 173 | 5 | GO:0001916 | |
| GeneOntologyBiologicalProcess | developmental growth | FOXO3 WWC3 HLA-B HLA-C SPTBN2 HLA-E HLA-F HLA-G PTGFRN TIAM1 SEMA5B PTPRS LRP4 MACF1 PRKN PRKG1 PLEC TNR GPAT4 SLC9A6 PCNT | 2.67e-05 | 911 | 173 | 21 | GO:0048589 |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 2.84e-05 | 233 | 173 | 10 | GO:0031345 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 2.91e-05 | 71 | 173 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 3.69e-05 | 74 | 173 | 6 | GO:0002711 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | WASHC2C HLA-B HLA-C FAT3 INPPL1 SPTBN1 SPTBN2 APC2 DCP2 HLA-E HLA-F HLA-G TRIOBP CRACD PTPRS LRP4 DLG4 PRKN TNR PACSIN2 | 3.96e-05 | 864 | 173 | 20 | GO:0051129 |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.98e-05 | 150 | 173 | 8 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 3.98e-05 | 150 | 173 | 8 | GO:0002708 | |
| GeneOntologyBiologicalProcess | actin filament capping | 4.07e-05 | 46 | 173 | 5 | GO:0051693 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 4.09e-05 | 195 | 173 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 4.21e-05 | 244 | 173 | 10 | GO:0006006 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 4.29e-05 | 76 | 173 | 6 | GO:0048002 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 4.69e-05 | 9 | 173 | 3 | GO:0042270 | |
| GeneOntologyBiologicalProcess | import into nucleus | 5.18e-05 | 201 | 173 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 5.35e-05 | 79 | 173 | 6 | GO:0001912 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 6.02e-05 | 159 | 173 | 8 | GO:0002821 | |
| GeneOntologyBiologicalProcess | positive regulation of retrograde transport, endosome to Golgi | 6.99e-05 | 2 | 173 | 2 | GO:1905281 | |
| GeneOntologyBiologicalProcess | neuron projection development | SETX HLA-B HLA-C SYNE1 CECR2 FAT3 INPPL1 HLA-E HLA-F HLA-G TRIOBP LAMC1 TIAM1 SEMA5B PTPRS SEC24B LRP4 MACF1 DLG4 PRKN PRKG1 HERC1 FBXO45 TNR SLC9A6 | 7.26e-05 | 1285 | 173 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 7.40e-05 | 52 | 173 | 5 | GO:0030835 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 8.12e-05 | 53 | 173 | 5 | GO:0001914 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 RAB23 RGPD2 RANBP2 RGPD8 FAM53A PPP1R12A SIRT7 MDN1 RGPD3 NUP133 RGPD5 | 8.70e-05 | 378 | 173 | 12 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 RAB23 RGPD2 RANBP2 RGPD8 FAM53A PPP1R12A SIRT7 MDN1 RGPD3 NUP133 RGPD5 | 8.70e-05 | 378 | 173 | 12 | GO:0006913 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 8.89e-05 | 54 | 173 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine trimethylation | 9.11e-05 | 11 | 173 | 3 | GO:0018023 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 9.80e-05 | 88 | 173 | 6 | GO:0031343 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.04e-04 | 89 | 173 | 6 | GO:1901880 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine methylation | 1.10e-04 | 30 | 173 | 4 | GO:0018022 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 1.18e-04 | 175 | 173 | 8 | GO:0002705 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.26e-04 | 132 | 173 | 7 | GO:0043255 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | WASHC2C KRT19 INPPL1 SPTBN1 SPTBN2 MYOM3 TRIOBP WASHC2A CRACD LDB3 INF2 PRKN ARHGAP25 PRKG1 PLEC MYO15A FGD6 PACSIN2 | 1.47e-04 | 803 | 173 | 18 | GO:0030036 |
| GeneOntologyBiologicalProcess | hexose metabolic process | 1.48e-04 | 284 | 173 | 10 | GO:0019318 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 1.50e-04 | 231 | 173 | 9 | GO:0006109 | |
| GeneOntologyBiologicalProcess | ear development | HLA-B HLA-C CECR2 HLA-E HLA-F HLA-G NKX3-2 TRIOBP SEC24B MYO15A | 1.52e-04 | 285 | 173 | 10 | GO:0043583 |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 1.59e-04 | 61 | 173 | 5 | GO:0030834 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.73e-04 | 185 | 173 | 8 | GO:0051168 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.98e-04 | 100 | 173 | 6 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | SETX HLA-B HLA-C SYNE1 FAT3 INPPL1 HLA-E HLA-F HLA-G TIAM1 PTPRS LRP4 MACF1 DLG4 TNR | 2.08e-04 | 612 | 173 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 2.17e-04 | 144 | 173 | 7 | GO:0043244 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | SETX WASHC2C CECR2 SPTBN1 SPTBN2 APC2 APAF1 TRIOBP LAMC1 CHMP7 CRACD TRNT1 SMARCC2 PRKN FBXW7 | 2.27e-04 | 617 | 173 | 15 | GO:0022411 |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 2.32e-04 | 66 | 173 | 5 | GO:0030042 | |
| GeneOntologyBiologicalProcess | actin filament-based process | WASHC2C DSG2 KRT19 INPPL1 SPTBN1 SPTBN2 MYOM3 TRIOBP WASHC2A CRACD LDB3 INF2 PRKN ARHGAP25 PRKG1 PLEC MYO15A FGD6 PACSIN2 | 2.44e-04 | 912 | 173 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 2.47e-04 | 247 | 173 | 9 | GO:0016051 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 2.59e-04 | 105 | 173 | 6 | GO:1901879 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 2.62e-04 | 249 | 173 | 9 | GO:0035264 | |
| GeneOntologyBiologicalProcess | cytosolic transport | 2.78e-04 | 150 | 173 | 7 | GO:0016482 | |
| GeneOntologyBiologicalProcess | inner ear development | 2.95e-04 | 253 | 173 | 9 | GO:0048839 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 2.99e-04 | 310 | 173 | 10 | GO:0005996 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 3.05e-04 | 70 | 173 | 5 | GO:0001913 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.45e-04 | 40 | 173 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 3.45e-04 | 40 | 173 | 4 | GO:0045954 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 3.49e-04 | 111 | 173 | 6 | GO:0002709 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 3.49e-04 | 111 | 173 | 6 | GO:0006094 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 3.80e-04 | 41 | 173 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of barbed-end actin filament capping | 4.15e-04 | 4 | 173 | 2 | GO:2000813 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 RAB23 RGPD2 RANBP2 RGPD8 FAM53A RGPD3 NUP133 MACF1 PRKN TIMM44 RGPD5 FBXW7 | 4.20e-04 | 515 | 173 | 13 | GO:0072594 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 4.21e-04 | 75 | 173 | 5 | GO:0030837 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 4.22e-04 | 115 | 173 | 6 | GO:0019319 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 4.47e-04 | 76 | 173 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated immunity | 4.99e-04 | 44 | 173 | 4 | GO:0002717 | |
| GeneOntologyBiologicalProcess | neuron development | SETX HLA-B HLA-C SYNE1 CECR2 FAT3 INPPL1 HLA-E HLA-F HLA-G TRIOBP LAMC1 TIAM1 SEMA5B PTPRS SEC24B LRP4 MACF1 DLG4 PRKN PRKG1 HERC1 FBXO45 TNR SLC9A6 | 5.29e-04 | 1463 | 173 | 25 | GO:0048666 |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 5.53e-04 | 121 | 173 | 6 | GO:0046364 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 5.67e-04 | 80 | 173 | 5 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 6.30e-04 | 124 | 173 | 6 | GO:0001910 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 6.44e-04 | 47 | 173 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.88e-04 | 5 | 173 | 2 | GO:0000472 | |
| GeneOntologyBiologicalProcess | rRNA 5'-end processing | 6.88e-04 | 5 | 173 | 2 | GO:0000967 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | HTR1D WASHC2C SPTBN1 SPTBN2 TRIOBP EXT2 CRACD INF2 PTPRS WDR35 MACF1 PRKG1 FGG TNR | 7.39e-04 | 618 | 173 | 14 | GO:0090066 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 7.83e-04 | 232 | 173 | 8 | GO:0002706 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | SETX HLA-B HLA-C SYNE1 FAT3 INPPL1 HLA-E HLA-F HLA-G PLEKHM1 TIAM1 PTPRS PPP1R16B LRP4 MACF1 DLG4 TNR | 7.83e-04 | 846 | 173 | 17 | GO:0120035 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 8.08e-04 | 291 | 173 | 9 | GO:0032984 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 7.37e-10 | 7 | 172 | 5 | GO:0032398 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.95e-09 | 8 | 172 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 8.67e-09 | 10 | 172 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 8.67e-09 | 10 | 172 | 5 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC protein complex | 5.71e-08 | 26 | 172 | 6 | GO:0042611 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 6.71e-08 | 14 | 172 | 5 | GO:0042824 | |
| GeneOntologyCellularComponent | annulate lamellae | 6.71e-08 | 14 | 172 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 2.03e-07 | 17 | 172 | 5 | GO:0033106 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.80e-07 | 18 | 172 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.79e-07 | 35 | 172 | 6 | GO:0098553 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.99e-07 | 20 | 172 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 6.51e-07 | 21 | 172 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 9.46e-07 | 64 | 172 | 7 | GO:0012507 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.06e-06 | 23 | 172 | 5 | GO:0005797 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.17e-06 | 42 | 172 | 6 | GO:0070971 | |
| GeneOntologyCellularComponent | early endosome membrane | WASHC2C HLA-B HLA-C HLA-E HLA-F KIF16B HLA-G SLC5A7 WASHC2A SLC9A6 DOP1B | 1.53e-06 | 212 | 172 | 11 | GO:0031901 |
| GeneOntologyCellularComponent | nuclear pore | 1.88e-06 | 101 | 172 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.62e-06 | 48 | 172 | 6 | GO:0098576 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 3.58e-06 | 110 | 172 | 8 | GO:0030134 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RGPD4 SLC37A1 RGPD2 RANBP2 EMC1 RGPD8 HLA-B HLA-C SYNE1 HLA-DRB3 HLA-E HLA-F HLA-G ATP10B EXT2 PTGFRN KSR1 THADA RGPD3 SEC24B SLMAP PDZD8 TMED9 PRKN NCEH1 SLC16A11 GPAT4 SLC9A6 | 3.96e-06 | 1327 | 172 | 28 | GO:0042175 |
| GeneOntologyCellularComponent | cis-Golgi network | 6.50e-06 | 85 | 172 | 7 | GO:0005801 | |
| GeneOntologyCellularComponent | inclusion body | 9.51e-06 | 90 | 172 | 7 | GO:0016234 | |
| GeneOntologyCellularComponent | endosome membrane | RAB23 WASHC2C HLA-B HLA-C HLA-DRB3 HLA-E HLA-F KIF16B HLA-G SLC5A7 ATP10B WASHC2A PLEKHM1 CHMP7 SLC9A6 PACSIN2 DOP1B | 1.03e-05 | 602 | 172 | 17 | GO:0010008 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT19 DYNC2H1 SYNE1 PPP1R12A SPTBN1 APC2 EML6 KIF16B MYOM3 AKNA STYXL2 EVPL TEKT5 CHMP7 LDB3 TIAM1 INF2 TTLL11 SLMAP NINL MACF1 EIF3A PLEC DNAH8 PCNT | 1.28e-05 | 1179 | 172 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT19 DYNC2H1 SYNE1 PPP1R12A SPTBN1 APC2 EML6 KIF16B MYOM3 AKNA STYXL2 EVPL TEKT5 CHMP7 LDB3 TIAM1 INF2 TTLL11 SLMAP NINL MACF1 EIF3A PLEC DNAH8 PCNT | 1.43e-05 | 1187 | 172 | 25 | GO:0099081 |
| GeneOntologyCellularComponent | recycling endosome membrane | 3.96e-05 | 112 | 172 | 7 | GO:0055038 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 4.82e-05 | 157 | 172 | 8 | GO:0045335 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 6.36e-05 | 83 | 172 | 6 | GO:0030670 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 7.98e-05 | 125 | 172 | 7 | GO:0140534 | |
| GeneOntologyCellularComponent | microtubule | DYNC2H1 APC2 EML6 KIF16B AKNA TEKT5 CHMP7 TIAM1 TTLL11 NINL MACF1 EIF3A DNAH8 PCNT | 1.38e-04 | 533 | 172 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT19 DYNC2H1 APC2 EML6 KIF16B AKNA EVPL TEKT5 CHMP7 LDB3 TIAM1 INF2 TTLL11 NINL MACF1 EIF3A PLEC DNAH8 PCNT | 1.59e-04 | 899 | 172 | 19 | GO:0099513 |
| GeneOntologyCellularComponent | transport vesicle membrane | HLA-B HLA-C HLA-DRB3 HLA-E HLA-F HLA-G SLC5A7 PTPRS SEC24B PRKN | 1.63e-04 | 293 | 172 | 10 | GO:0030658 |
| GeneOntologyCellularComponent | Parkin-FBXW7-Cul1 ubiquitin ligase complex | 2.01e-04 | 3 | 172 | 2 | GO:1990452 | |
| GeneOntologyCellularComponent | sarcomere | 2.28e-04 | 249 | 172 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | SCF ubiquitin ligase complex | 2.80e-04 | 70 | 172 | 5 | GO:0019005 | |
| GeneOntologyCellularComponent | endocytic vesicle | RAB23 HLA-B HLA-C HLA-DRB3 HLA-E HLA-F KIF16B HLA-G SLC5A7 STXBP3 DLG4 | 3.51e-04 | 384 | 172 | 11 | GO:0030139 |
| GeneOntologyCellularComponent | transport vesicle | HLA-B HLA-C HLA-DRB3 SPTBN2 HLA-E HLA-F HLA-G SLC5A7 PTPRS SEC24B TMED9 DLG4 PRKN | 3.77e-04 | 519 | 172 | 13 | GO:0030133 |
| GeneOntologyCellularComponent | transferase complex | RGPD4 RGPD2 RANBP2 RGPD8 EXT2 PFKM DCAF5 CCNH PHKG2 KANSL2 FBXO9 FBH1 DCAF10 RGPD3 PAXIP1 PRKN WDFY3 FBXO45 FBXW7 | 3.78e-04 | 963 | 172 | 19 | GO:1990234 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 3.81e-04 | 212 | 172 | 8 | GO:0030666 | |
| GeneOntologyCellularComponent | autolysosome membrane | 4.00e-04 | 4 | 172 | 2 | GO:0120281 | |
| GeneOntologyCellularComponent | myofibril | 4.47e-04 | 273 | 172 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | RAB23 WASHC2C HLA-B HLA-C HLA-DRB3 HLA-E HLA-F KIF16B HLA-G SLC5A7 ATP10B WASHC2A PLEKHM1 CHMP7 PTPRS SEC24B DLG4 PRKN SLC9A6 ARHGAP21 CCDC136 PACSIN2 DOP1B | 4.62e-04 | 1307 | 172 | 23 | GO:0030659 |
| GeneOntologyCellularComponent | recycling endosome | 5.18e-04 | 222 | 172 | 8 | GO:0055037 | |
| GeneOntologyCellularComponent | vesicle membrane | RAB23 WASHC2C HLA-B HLA-C HLA-DRB3 HLA-E HLA-F KIF16B HLA-G SLC5A7 ATP10B WASHC2A PLEKHM1 CHMP7 PTPRS SEC24B DLG4 PRKN SLC9A6 ARHGAP21 CCDC136 PACSIN2 DOP1B | 5.58e-04 | 1325 | 172 | 23 | GO:0012506 |
| GeneOntologyCellularComponent | endosome | RAB23 WASHC2C HLA-B HLA-C HLA-DRB3 SPTBN2 HLA-E HLA-F KIF16B HLA-G SLC5A7 ATP10B EIPR1 WASHC2A BIRC6 ADCY5 PLEKHM1 CHMP7 SLC9A6 PACSIN2 DOP1B | 6.22e-04 | 1167 | 172 | 21 | GO:0005768 |
| GeneOntologyCellularComponent | early endosome | WASHC2C HLA-B HLA-C HLA-E HLA-F KIF16B HLA-G SLC5A7 WASHC2A SLC9A6 PACSIN2 DOP1B | 6.56e-04 | 481 | 172 | 12 | GO:0005769 |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.89e-04 | 290 | 172 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | membrane raft | 8.60e-04 | 362 | 172 | 10 | GO:0045121 | |
| GeneOntologyCellularComponent | A band | 8.81e-04 | 52 | 172 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | membrane microdomain | 8.96e-04 | 364 | 172 | 10 | GO:0098857 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SLC37A1 EMC1 HLA-B HLA-C HLA-DRB3 HLA-E HLA-F HLA-G ATP10B EXT2 PTGFRN KSR1 THADA SEC24B SLMAP PDZD8 TMED9 PRKN NCEH1 SLC16A11 GPAT4 SLC9A6 | 9.63e-04 | 1293 | 172 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SLC37A1 EMC1 HLA-B HLA-C HLA-DRB3 HLA-E HLA-F HLA-G ATP10B EXT2 PTGFRN KSR1 THADA SEC24B SLMAP PDZD8 TMED9 PRKN NCEH1 SLC16A11 GPAT4 SLC9A6 | 1.02e-03 | 1299 | 172 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | leading edge membrane | 1.81e-03 | 210 | 172 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 1.91e-03 | 212 | 172 | 7 | GO:0031461 | |
| GeneOntologyCellularComponent | ruffle membrane | 2.00e-03 | 108 | 172 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 2.06e-03 | 215 | 172 | 7 | GO:0030662 | |
| GeneOntologyCellularComponent | M band | 2.08e-03 | 31 | 172 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.33e-03 | 9 | 172 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 2.33e-03 | 9 | 172 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | nuclear membrane | 2.47e-03 | 349 | 172 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | actin cytoskeleton | KRT19 PPP1R12A SPTBN1 SPTBN2 APC2 TRIOBP LDB3 KANSL2 INF2 MACF1 MYO15A ARHGAP21 | 2.99e-03 | 576 | 172 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | coated vesicle | 3.04e-03 | 360 | 172 | 9 | GO:0030135 | |
| GeneOntologyCellularComponent | vacuolar membrane | HLA-B HLA-C HLA-DRB3 HLA-E HLA-F HLA-G ATP10B PLEKHM1 CHMP7 SLC38A7 WDFY3 | 3.26e-03 | 507 | 172 | 11 | GO:0005774 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | HLA-B HLA-C HLA-DRB3 HLA-E HLA-F HLA-G EIPR1 BIRC6 PACSIN2 DOP1B | 3.76e-03 | 443 | 172 | 10 | GO:0098791 |
| GeneOntologyCellularComponent | neuron to neuron synapse | SPTBN1 GRIK5 TIAM1 PTPRS LRP4 MACF1 DLG4 PRKN EIF3A FBXO45 TNR | 4.12e-03 | 523 | 172 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | 4.26e-03 | 451 | 172 | 10 | GO:0014069 | |
| GeneOntologyCellularComponent | lysosomal membrane | HLA-B HLA-C HLA-DRB3 HLA-E HLA-F HLA-G ATP10B PLEKHM1 CHMP7 SLC38A7 | 5.04e-03 | 462 | 172 | 10 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | HLA-B HLA-C HLA-DRB3 HLA-E HLA-F HLA-G ATP10B PLEKHM1 CHMP7 SLC38A7 | 5.04e-03 | 462 | 172 | 10 | GO:0098852 |
| GeneOntologyCellularComponent | Golgi cisterna | 5.22e-03 | 135 | 172 | 5 | GO:0031985 | |
| GeneOntologyCellularComponent | ISWI-type complex | 5.74e-03 | 14 | 172 | 2 | GO:0031010 | |
| GeneOntologyCellularComponent | asymmetric synapse | 6.27e-03 | 477 | 172 | 10 | GO:0032279 | |
| GeneOntologyCellularComponent | WASH complex | 6.59e-03 | 15 | 172 | 2 | GO:0071203 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 RGPD2 RANBP2 RGPD8 SYNE1 CHMP7 CLCA2 RGPD3 NUP133 WDFY3 RGPD5 | 6.79e-03 | 560 | 172 | 11 | GO:0005635 |
| GeneOntologyCellularComponent | ruffle | 7.27e-03 | 206 | 172 | 6 | GO:0001726 | |
| GeneOntologyCellularComponent | intercellular bridge | 7.60e-03 | 94 | 172 | 4 | GO:0045171 | |
| GeneOntologyCellularComponent | Z disc | 8.30e-03 | 151 | 172 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 8.44e-03 | 17 | 172 | 2 | GO:0098637 | |
| MousePheno | spinal cord inflammation | 5.51e-09 | 8 | 142 | 5 | MP:0030987 | |
| MousePheno | increased NK cell number | 1.39e-07 | 82 | 142 | 9 | MP:0008044 | |
| MousePheno | decreased immature NK cell number | 1.87e-07 | 14 | 142 | 5 | MP:0013666 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 4.02e-07 | 16 | 142 | 5 | MP:0003701 | |
| MousePheno | decreased tumor latency | 4.80e-07 | 30 | 142 | 6 | MP:0010308 | |
| MousePheno | decreased mature NK cell number | 7.76e-07 | 18 | 142 | 5 | MP:0013672 | |
| MousePheno | abnormal immature NK cell number | 1.05e-06 | 19 | 142 | 5 | MP:0013665 | |
| MousePheno | abnormal immature NK cell morphology | 1.05e-06 | 19 | 142 | 5 | MP:0013699 | |
| MousePheno | abnormal tumor latency | 1.05e-06 | 34 | 142 | 6 | MP:0010307 | |
| MousePheno | cystolithiasis | 2.31e-06 | 22 | 142 | 5 | MP:0011625 | |
| MousePheno | abnormal mature NK cell number | 3.67e-06 | 24 | 142 | 5 | MP:0013671 | |
| MousePheno | abnormal mature NK cell morphology | 4.55e-06 | 25 | 142 | 5 | MP:0013700 | |
| MousePheno | abnormal morula morphology | 5.58e-06 | 26 | 142 | 5 | MP:0012058 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 5.81e-06 | 45 | 142 | 6 | MP:0004804 | |
| MousePheno | abnormal mitosis | 6.11e-06 | 128 | 142 | 9 | MP:0004046 | |
| MousePheno | urolithiasis | 1.38e-05 | 31 | 142 | 5 | MP:0005360 | |
| MousePheno | failure of blastocyst formation | 1.38e-05 | 31 | 142 | 5 | MP:0012129 | |
| MousePheno | abnormal blastocyst formation | 4.39e-05 | 39 | 142 | 5 | MP:0012128 | |
| MousePheno | abnormal NK cell number | 6.46e-05 | 172 | 142 | 9 | MP:0008043 | |
| MousePheno | increased hepatocellular carcinoma incidence | 7.60e-05 | 70 | 142 | 6 | MP:0003331 | |
| MousePheno | increased sarcoma incidence | 7.95e-05 | 102 | 142 | 7 | MP:0002032 | |
| MousePheno | decreased macrophage nitric oxide production | 8.24e-05 | 9 | 142 | 3 | MP:0011077 | |
| MousePheno | decreased activated T cell number | 8.24e-05 | 9 | 142 | 3 | MP:0001830 | |
| MousePheno | abnormal NK cell morphology | 1.04e-04 | 183 | 142 | 9 | MP:0005068 | |
| MousePheno | decreased gamma-delta T cell number | 1.10e-04 | 47 | 142 | 5 | MP:0008347 | |
| MousePheno | increased lung carcinoma incidence | 1.39e-04 | 78 | 142 | 6 | MP:0008714 | |
| MousePheno | small lung | 1.69e-04 | 115 | 142 | 7 | MP:0003641 | |
| MousePheno | CNS inflammation | 2.14e-04 | 54 | 142 | 5 | MP:0006082 | |
| MousePheno | demyelination | 2.24e-04 | 85 | 142 | 6 | MP:0000921 | |
| MousePheno | abnormal macrophage nitric oxide production | 2.72e-04 | 13 | 142 | 3 | MP:0011074 | |
| MousePheno | abnormal T cell activation | FOXO3 HLA-B HLA-C HLA-E HLA-F HLA-G KSR1 CD5 CIITA DCLRE1C CD226 | 3.32e-04 | 311 | 142 | 11 | MP:0001828 |
| MousePheno | impaired glucose tolerance | RGPD4 FOXO3 RGPD2 FAM86B1 RANBP2 FAM86B2 RGPD8 PFKM EEF2KMT STXBP3 FAM86C1P RGPD3 HERC1 HDC | 3.78e-04 | 480 | 142 | 14 | MP:0005293 |
| MousePheno | aneuploidy | 3.80e-04 | 61 | 142 | 5 | MP:0004024 | |
| MousePheno | decreased susceptibility to autoimmune disorder | 5.01e-04 | 180 | 142 | 8 | MP:0005351 | |
| MousePheno | enlarged epididymis | 5.10e-04 | 99 | 142 | 6 | MP:0004931 | |
| MousePheno | skin detachment | 6.07e-04 | 4 | 142 | 2 | MP:0009827 | |
| MousePheno | abnormal gamma-delta T cell number | 6.72e-04 | 69 | 142 | 5 | MP:0008345 | |
| MousePheno | abnormal memory T cell physiology | 7.49e-04 | 18 | 142 | 3 | MP:0008051 | |
| MousePheno | abnormal lung morphology | RGPD4 RGPD2 RANBP2 RGPD8 DYNC2H1 SYNE1 SPTBN1 PKD1L1 TRPS1 LAMC1 NHSL1 RGPD3 SEC24B WDR35 LRP4 PROP1 PCNT FBXW7 | 7.65e-04 | 767 | 142 | 18 | MP:0001175 |
| MousePheno | increased respiratory system tumor incidence | 7.70e-04 | 107 | 142 | 6 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 7.70e-04 | 107 | 142 | 6 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 7.70e-04 | 107 | 142 | 6 | MP:0003694 | |
| Domain | Ran_BP1 | 5.29e-10 | 12 | 174 | 6 | PF00638 | |
| Domain | RANBD1 | 5.29e-10 | 12 | 174 | 6 | PS50196 | |
| Domain | RanBD | 9.75e-10 | 13 | 174 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 9.75e-10 | 13 | 174 | 6 | IPR000156 | |
| Domain | FAM86 | 7.28e-09 | 4 | 174 | 4 | IPR029426 | |
| Domain | FAM86 | 7.28e-09 | 4 | 174 | 4 | PF14904 | |
| Domain | Grip | 2.93e-08 | 11 | 174 | 5 | SM00755 | |
| Domain | GRIP | 2.93e-08 | 11 | 174 | 5 | PF01465 | |
| Domain | GRIP_dom | 4.98e-08 | 12 | 174 | 5 | IPR000237 | |
| Domain | GRIP | 4.98e-08 | 12 | 174 | 5 | PS50913 | |
| Domain | MHC_I_a_C | 1.08e-07 | 6 | 174 | 4 | IPR010579 | |
| Domain | MHC_I_C | 1.08e-07 | 6 | 174 | 4 | PF06623 | |
| Domain | Spectrin_repeat | 2.38e-07 | 29 | 174 | 6 | IPR002017 | |
| Domain | Rab_bind | 2.49e-07 | 7 | 174 | 4 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.49e-07 | 7 | 174 | 4 | IPR032023 | |
| Domain | SPEC | 4.45e-07 | 32 | 174 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 4.45e-07 | 32 | 174 | 6 | IPR018159 | |
| Domain | - | EML6 APAF1 WDR25 EIPR1 BIRC6 TBL3 DCAF5 DCAF10 SEMA5B NUP133 WDR35 NLE1 WDFY3 HERC1 FBXW7 | 5.53e-07 | 333 | 174 | 15 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | EML6 APAF1 WDR25 EIPR1 BIRC6 TBL3 DCAF5 DCAF10 SEMA5B NUP133 WDR35 NLE1 WDFY3 HERC1 FBXW7 | 5.96e-07 | 335 | 174 | 15 | IPR015943 |
| Domain | MHC_I | 1.19e-06 | 21 | 174 | 5 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.19e-06 | 21 | 174 | 5 | IPR001039 | |
| Domain | MHC_I/II-like_Ag-recog | 1.29e-06 | 38 | 174 | 6 | IPR011162 | |
| Domain | - | 1.46e-06 | 10 | 174 | 4 | 1.10.220.60 | |
| Domain | ACTININ_2 | 1.95e-06 | 23 | 174 | 5 | PS00020 | |
| Domain | ACTININ_1 | 1.95e-06 | 23 | 174 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.95e-06 | 23 | 174 | 5 | IPR001589 | |
| Domain | - | 2.44e-06 | 24 | 174 | 5 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 2.44e-06 | 24 | 174 | 5 | IPR011161 | |
| Domain | PH_dom-like | RGPD4 RGPD2 RANBP2 RGPD8 SPTBN1 SPTBN2 TRIOBP ARHGEF16 PLEKHM1 TIAM1 RGPD3 ARHGAP25 WDFY3 FGD6 ARHGAP21 RGPD5 | 2.50e-06 | 426 | 174 | 16 | IPR011993 |
| Domain | WD40 | EML6 APAF1 WDR25 EIPR1 TBL3 DCAF5 DCAF10 WDR35 NLE1 WDFY3 HERC1 FBXW7 | 5.87e-06 | 259 | 174 | 12 | PF00400 |
| Domain | WD40 | EML6 APAF1 WDR25 EIPR1 TBL3 DCAF5 DCAF10 WDR35 NLE1 WDFY3 HERC1 FBXW7 | 8.29e-06 | 268 | 174 | 12 | SM00320 |
| Domain | WD40_repeat | EML6 APAF1 WDR25 EIPR1 TBL3 DCAF5 DCAF10 WDR35 NLE1 WDFY3 HERC1 FBXW7 | 9.63e-06 | 272 | 174 | 12 | IPR001680 |
| Domain | C1-set | 1.07e-05 | 54 | 174 | 6 | PF07654 | |
| Domain | WD_REPEATS_1 | EML6 APAF1 WDR25 EIPR1 TBL3 DCAF5 DCAF10 WDR35 NLE1 WDFY3 HERC1 FBXW7 | 1.20e-05 | 278 | 174 | 12 | PS00678 |
| Domain | WD_REPEATS_2 | EML6 APAF1 WDR25 EIPR1 TBL3 DCAF5 DCAF10 WDR35 NLE1 WDFY3 HERC1 FBXW7 | 1.24e-05 | 279 | 174 | 12 | PS50082 |
| Domain | WD_REPEATS_REGION | EML6 APAF1 WDR25 EIPR1 TBL3 DCAF5 DCAF10 WDR35 NLE1 WDFY3 HERC1 FBXW7 | 1.24e-05 | 279 | 174 | 12 | PS50294 |
| Domain | IGc1 | 1.32e-05 | 56 | 174 | 6 | SM00407 | |
| Domain | - | 1.56e-05 | 6 | 174 | 3 | 3.90.1290.10 | |
| Domain | Ig/MHC_CS | 1.62e-05 | 58 | 174 | 6 | IPR003006 | |
| Domain | Ig_C1-set | 1.62e-05 | 58 | 174 | 6 | IPR003597 | |
| Domain | - | RGPD4 RGPD2 RANBP2 RGPD8 SPTBN1 SPTBN2 TRIOBP ARHGEF16 PLEKHM1 TIAM1 RGPD3 ARHGAP25 FGD6 ARHGAP21 | 1.86e-05 | 391 | 174 | 14 | 2.30.29.30 |
| Domain | IG_MHC | 1.98e-05 | 60 | 174 | 6 | PS00290 | |
| Domain | WD40_repeat_dom | EML6 APAF1 WDR25 EIPR1 TBL3 DCAF5 DCAF10 WDR35 NLE1 WDFY3 HERC1 FBXW7 | 2.31e-05 | 297 | 174 | 12 | IPR017986 |
| Domain | WD40_repeat_CS | 2.36e-05 | 164 | 174 | 9 | IPR019775 | |
| Domain | Plectin | 2.71e-05 | 7 | 174 | 3 | PF00681 | |
| Domain | Plectin_repeat | 2.71e-05 | 7 | 174 | 3 | IPR001101 | |
| Domain | PLEC | 2.71e-05 | 7 | 174 | 3 | SM00250 | |
| Domain | Spectrin | 5.61e-05 | 23 | 174 | 4 | PF00435 | |
| Domain | PH_dom-spectrin-type | 6.41e-05 | 9 | 174 | 3 | IPR001605 | |
| Domain | FAM21 | 8.63e-05 | 2 | 174 | 2 | IPR027308 | |
| Domain | Methyltransf_16 | 1.24e-04 | 11 | 174 | 3 | IPR019410 | |
| Domain | Methyltransf_16 | 1.24e-04 | 11 | 174 | 3 | PF10294 | |
| Domain | CAP-ZIP_m | 2.57e-04 | 3 | 174 | 2 | PF15255 | |
| Domain | FAM21/CAPZIP | 2.57e-04 | 3 | 174 | 2 | IPR029341 | |
| Domain | ATPase_dyneun-rel_AAA | 2.68e-04 | 14 | 174 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.68e-04 | 14 | 174 | 3 | PF07728 | |
| Domain | CH | 3.48e-04 | 65 | 174 | 5 | SM00033 | |
| Domain | CH | 4.92e-04 | 70 | 174 | 5 | PF00307 | |
| Domain | Spectrin_bsu | 5.11e-04 | 4 | 174 | 2 | IPR016343 | |
| Domain | TPR-contain_dom | 5.20e-04 | 150 | 174 | 7 | IPR013026 | |
| Domain | - | 5.25e-04 | 71 | 174 | 5 | 1.10.418.10 | |
| Domain | CH | 5.97e-04 | 73 | 174 | 5 | PS50021 | |
| Domain | CH-domain | 6.75e-04 | 75 | 174 | 5 | IPR001715 | |
| Domain | F-box-like | 7.39e-04 | 44 | 174 | 4 | PF12937 | |
| Domain | TPR_REGION | 9.13e-04 | 165 | 174 | 7 | PS50293 | |
| Domain | TPR | 9.13e-04 | 165 | 174 | 7 | PS50005 | |
| Domain | PH | SPTBN1 SPTBN2 TRIOBP ARHGEF16 PLEKHM1 TIAM1 ARHGAP25 FGD6 ARHGAP21 | 1.22e-03 | 278 | 174 | 9 | SM00233 |
| Domain | PH_DOMAIN | SPTBN1 SPTBN2 TRIOBP ARHGEF16 PLEKHM1 TIAM1 ARHGAP25 FGD6 ARHGAP21 | 1.25e-03 | 279 | 174 | 9 | PS50003 |
| Domain | PH_domain | SPTBN1 SPTBN2 TRIOBP ARHGEF16 PLEKHM1 TIAM1 ARHGAP25 FGD6 ARHGAP21 | 1.28e-03 | 280 | 174 | 9 | IPR001849 |
| Domain | PH | 1.40e-03 | 229 | 174 | 8 | PF00169 | |
| Domain | TPR-like_helical_dom | 1.56e-03 | 233 | 174 | 8 | IPR011990 | |
| Domain | PDZ | 2.08e-03 | 141 | 174 | 6 | PF00595 | |
| Domain | DHC_N1 | 2.33e-03 | 8 | 174 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.33e-03 | 8 | 174 | 2 | IPR013594 | |
| Domain | PDZ | 2.66e-03 | 148 | 174 | 6 | SM00228 | |
| Domain | - | 2.84e-03 | 150 | 174 | 6 | 2.30.42.10 | |
| Domain | PDZ | 2.94e-03 | 151 | 174 | 6 | PS50106 | |
| Domain | PDZ | 3.03e-03 | 152 | 174 | 6 | IPR001478 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.29e-10 | 6 | 134 | 5 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.49e-09 | 7 | 134 | 5 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.49e-09 | 7 | 134 | 5 | M47530 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 8.80e-09 | 9 | 134 | 5 | MM14527 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 3.18e-08 | 11 | 134 | 5 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 5.41e-08 | 12 | 134 | 5 | M47529 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 1.01e-07 | 25 | 134 | 6 | MM15713 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 2.62e-07 | 29 | 134 | 6 | M1062 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 5.59e-07 | 18 | 134 | 5 | MM1549 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 5.59e-07 | 18 | 134 | 5 | MM14525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 9.95e-07 | 20 | 134 | 5 | MM1374 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.07e-06 | 82 | 134 | 8 | MM15394 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.20e-06 | 37 | 134 | 6 | M18615 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.94e-06 | 40 | 134 | 6 | MM14945 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 2.26e-06 | 41 | 134 | 6 | M13519 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.26e-06 | 41 | 134 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.61e-06 | 42 | 134 | 6 | MM15039 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 3.01e-06 | 43 | 134 | 6 | M12617 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.01e-06 | 43 | 134 | 6 | MM14609 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 3.28e-06 | 25 | 134 | 5 | MM1465 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 5.14e-06 | 47 | 134 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 6.59e-06 | 49 | 134 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 7.43e-06 | 50 | 134 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 8.36e-06 | 51 | 134 | 6 | MM15151 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 9.38e-06 | 52 | 134 | 6 | M13103 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.30e-05 | 55 | 134 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.78e-05 | 58 | 134 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.78e-05 | 58 | 134 | 6 | MM14736 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 2.01e-05 | 88 | 134 | 7 | M16004 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 2.65e-05 | 126 | 134 | 8 | M45009 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.44e-05 | 65 | 134 | 6 | MM15147 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 4.04e-05 | 98 | 134 | 7 | M965 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 4.60e-05 | 100 | 134 | 7 | MM14561 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 5.00e-05 | 22 | 134 | 4 | MM15519 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 5.25e-05 | 70 | 134 | 6 | M12294 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 6.66e-05 | 73 | 134 | 6 | MM14948 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.25e-04 | 117 | 134 | 7 | MM15387 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.46e-04 | 84 | 134 | 6 | MM14929 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.57e-04 | 54 | 134 | 5 | MM14871 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.66e-04 | 86 | 134 | 6 | MM15413 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 1.86e-04 | 56 | 134 | 5 | MM15901 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 2.01e-04 | 89 | 134 | 6 | M39398 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.29e-04 | 129 | 134 | 7 | MM14894 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.41e-04 | 92 | 134 | 6 | MM14951 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | RGPD4 SLC37A1 RGPD2 RANBP2 RGPD8 EXT2 PFKM PHKG2 RGPD3 NUP133 | 2.63e-04 | 271 | 134 | 10 | MM15406 |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 2.76e-04 | 133 | 134 | 7 | M16476 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 3.02e-04 | 62 | 134 | 5 | M39639 | |
| Pathway | WP_TAR_SYNDROME | 3.25e-04 | 63 | 134 | 5 | M48082 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 3.94e-04 | 141 | 134 | 7 | MM15266 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 5.17e-04 | 106 | 134 | 6 | M518 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | RGPD4 RAB23 RGPD2 FAM86B1 NRIP1 RANBP2 FAM86B2 RGPD8 ARSK SPTBN1 SPTBN2 MUC19 DCAF5 EEF2KMT FBXO9 FAM86C1P DCAF10 SEMA5B TTLL11 RGPD3 SEC24B NUP133 TMED9 PRKN FGG FBXW7 | 5.63e-04 | 1389 | 134 | 26 | MM15307 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 6.90e-04 | 202 | 134 | 8 | MM15362 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 7.36e-04 | 204 | 134 | 8 | M45011 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 7.60e-04 | 114 | 134 | 6 | MM15361 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 7.75e-04 | 76 | 134 | 5 | MM14526 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 7.78e-04 | 257 | 134 | 9 | MM14755 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 8.72e-04 | 78 | 134 | 5 | M973 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | HLA-B HLA-C HLA-E HLA-F HLA-G FBXO9 SEC24B PRKN FGG HERC1 FBXW7 | 1.03e-03 | 381 | 134 | 11 | M1066 |
| Pathway | REACTOME_SUMOYLATION | 1.15e-03 | 169 | 134 | 7 | MM14919 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.19e-03 | 273 | 134 | 9 | M983 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_INTRINSIC_APOPTOTIC_PATHWAY | 1.31e-03 | 6 | 134 | 2 | M47708 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 1.44e-03 | 129 | 134 | 6 | M39693 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 1.61e-03 | 343 | 134 | 10 | MM15712 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.77e-03 | 234 | 134 | 8 | MM14898 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.82e-03 | 135 | 134 | 6 | MM14781 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01050 | 1.83e-03 | 7 | 134 | 2 | M47709 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 2.22e-03 | 299 | 134 | 9 | M41727 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.46e-03 | 193 | 134 | 7 | MM14890 | |
| Pubmed | EMC1 HLA-C CENPC DSG2 DYNC2H1 SYNE1 SPTBN1 SPTBN2 APAF1 KIF16B TRIOBP LAMC1 EXT2 ITPRID2 PFKM WASHC2A TBL3 DCAF5 CHMP7 THADA NOP14 MDN1 STXBP3 TIAM1 INF2 SLMAP NUP133 PDZD8 NLE1 MACF1 SIPA1L2 TIMM44 GPAT4 PACSIN2 PCNT | 2.89e-14 | 1487 | 177 | 35 | 33957083 | |
| Pubmed | 1.32e-12 | 9 | 177 | 6 | 2894206 | ||
| Pubmed | An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus. | 1.32e-12 | 9 | 177 | 6 | 22084437 | |
| Pubmed | Pivotal roles of CD8+ T cells restricted by MHC class I-like molecules in autoimmune diseases. | 1.32e-12 | 9 | 177 | 6 | 17088432 | |
| Pubmed | 1.32e-12 | 9 | 177 | 6 | 18292501 | ||
| Pubmed | RGPD4 RGPD2 RANBP2 RGPD8 CENPC KRT19 SYNE1 PPP1R12A SPTBN1 SPTBN2 EML6 ATP10B PFKM GPALPP1 CCNH TRNT1 NOP14 MDN1 BAZ1A EIF4B RGPD3 SMARCC2 NLE1 MACF1 EIF3A PLEC SIPA1L2 DNAH8 ARHGAP21 GABPA PCNT RGPD5 | 2.06e-12 | 1442 | 177 | 32 | 35575683 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 SETX EMC1 DSG2 KRT19 PPP1R12A INPPL1 SPTBN1 DCP2 LAMC1 GIGYF1 ITPRID2 ARHGEF16 NHSL1 KSR1 MDN1 TIAM1 EIF4B SEC24B MACF1 PLEC SIPA1L2 FGD6 ARHGAP21 DOP1B | 2.43e-12 | 861 | 177 | 25 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 PITPNM2 INPPL1 KHNYN MYOM3 AKNA WASHC2A BIRC6 PLEKHM1 TBC1D9 NHSL1 THADA MDN1 INF2 PTPRS PAXIP1 NINL LRP4 PDZD8 NLE1 WDFY3 PLEC ZNF324B HERC1 SIPA1L2 GPAT4 ARHGAP21 PCNT | 2.68e-12 | 1105 | 177 | 28 | 35748872 |
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 3.29e-12 | 10 | 177 | 6 | 16332688 | |
| Pubmed | Expression of CD226 is associated to but not required for NK cell education. | 7.22e-12 | 11 | 177 | 6 | 28561023 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 10982373 | ||
| Pubmed | Multiple receptors converge on H2-Q10 to regulate NK and γδT-cell development. | 1.93e-11 | 6 | 177 | 5 | 30537346 | |
| Pubmed | A nonpolymorphic class I gene in the murine major histocompatibility complex. | 1.93e-11 | 6 | 177 | 5 | 6420070 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 11932387 | ||
| Pubmed | Three classes of mouse H-2 messenger RNA distinguished by analysis of cDNA clones. | 1.93e-11 | 6 | 177 | 5 | 6276751 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 9730897 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 8671651 | ||
| Pubmed | The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC. | 1.93e-11 | 6 | 177 | 5 | 10366557 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 6411351 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 9582271 | ||
| Pubmed | Organization of the AKR Qa region: structure of a divergent class I sequence, Q5k. | 1.93e-11 | 6 | 177 | 5 | 2639903 | |
| Pubmed | Characteristics of the expression of the murine soluble class I molecule (Q10). | 1.93e-11 | 6 | 177 | 5 | 3940270 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 7836920 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 8283431 | ||
| Pubmed | QUOD ERAT FACIENDUM: sequence analysis of the H2-D and H2-Q regions of 129/SvJ mice. | 1.93e-11 | 6 | 177 | 5 | 12389096 | |
| Pubmed | Occurrence of a unique MHC class I gene in distantly related members of the genus Mus. | 1.93e-11 | 6 | 177 | 5 | 3988322 | |
| Pubmed | Correlation of Qa-1 determinants defined by antisera and by cytotoxic T lymphocytes. | 1.93e-11 | 6 | 177 | 5 | 2580784 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 2228044 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 6304710 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 6822734 | ||
| Pubmed | Spatial-Temporal Expression of Non-classical MHC Class I Molecules in the C57 Mouse Brain. | 1.93e-11 | 6 | 177 | 5 | 26040564 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 28894277 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 3925004 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 10546855 | ||
| Pubmed | Qa antigens and their differential distribution on lymphoid, myeloid and stem cells. | 1.93e-11 | 6 | 177 | 5 | 6399516 | |
| Pubmed | Polymorphism of a Qa-1-associated antigen defined by cytotoxic T cells. I. Qed-1a and Qed-1d. | 1.93e-11 | 6 | 177 | 5 | 6978819 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 10799863 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 14595379 | ||
| Pubmed | HIV immune evasion disruption of antigen presentation by the HIV Nef protein. | 1.93e-11 | 6 | 177 | 5 | 21762823 | |
| Pubmed | Identification of a recombinogenic major histocompatibility complex Q gene with diverse alleles. | 1.93e-11 | 6 | 177 | 5 | 8496692 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 2767053 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 6967411 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 9373217 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 7026427 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 19555986 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 9120272 | ||
| Pubmed | Embryonal carcinoma cells express Qa and Tla class I genes of the major histocompatibility complex. | 1.93e-11 | 6 | 177 | 5 | 2740345 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 6961454 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 2416805 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 9840288 | ||
| Pubmed | A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. | 1.93e-11 | 6 | 177 | 5 | 2789433 | |
| Pubmed | Spatial and functional relationship of GGAs and AP-1 in Drosophila and HeLa cells. | 1.93e-11 | 6 | 177 | 5 | 19847956 | |
| Pubmed | Recognition of alternate alleles and mapping of the Qa1 locus. | 1.93e-11 | 6 | 177 | 5 | 7276576 | |
| Pubmed | Repression of MHC class I gene promoter activity by two-exon Tat of HIV. | 1.93e-11 | 6 | 177 | 5 | 8493575 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 8732475 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 22503975 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 9368027 | ||
| Pubmed | Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes. | 1.93e-11 | 6 | 177 | 5 | 8877415 | |
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 8612235 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 2592022 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 1705528 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 2808323 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 9586638 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 21088134 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 69663 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 6.72e-11 | 7 | 177 | 5 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 6.72e-11 | 7 | 177 | 5 | 6264319 | |
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 6.72e-11 | 7 | 177 | 5 | 2714856 | |
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 10500200 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 6.72e-11 | 7 | 177 | 5 | 2391419 | |
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 15671142 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 14215561 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 6.72e-11 | 7 | 177 | 5 | 28234229 | |
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 6.72e-11 | 7 | 177 | 5 | 6242891 | |
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 17512611 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 7018573 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 2642506 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 9037092 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 9037062 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 19643141 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 1840571 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 20957233 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 11580250 | ||
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 6.72e-11 | 7 | 177 | 5 | 11086076 | |
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 12750360 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 18416856 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 6.72e-11 | 7 | 177 | 5 | 20974936 | |
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 10704462 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 22573867 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 6.72e-11 | 7 | 177 | 5 | 2908875 | |
| Pubmed | Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse. | 6.72e-11 | 7 | 177 | 5 | 2584927 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 6.72e-11 | 7 | 177 | 5 | 15710750 | |
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 3496275 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 12147629 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 3458188 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 12414957 | ||
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 19462379 | ||
| Pubmed | Structural diversity of the classical H-2 genes: K, D, and L. | 6.72e-11 | 7 | 177 | 5 | 1730883 | |
| Pubmed | 6.72e-11 | 7 | 177 | 5 | 3680952 | ||
| Pubmed | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | 6.72e-11 | 7 | 177 | 5 | 19004778 | |
| Interaction | YWHAH interactions | FOXO3 NRIP1 SETX EMC1 DSG2 KRT19 PPP1R12A INPPL1 SPTBN1 GIGYF1 ITPRID2 KRR1 ARHGEF16 NHSL1 KSR1 FAM86C1P TIAM1 EIF4B SEC24B NINL MACF1 PRKN PLEC HERC1 SIPA1L2 FBXO45 FGD6 ARHGAP21 DOP1B PCNT | 2.02e-08 | 1102 | 174 | 30 | int:YWHAH |
| Interaction | RGPD4 interactions | 2.53e-08 | 22 | 174 | 6 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 9.68e-08 | 27 | 174 | 6 | int:RGPD2 | |
| Interaction | SFN interactions | FOXO3 DSG2 KRT19 PPP1R12A SPTBN1 GIGYF1 ITPRID2 ARHGEF16 TBL3 CCNH KSR1 FAM86C1P TIAM1 EIF4B NINL MACF1 PRKN PLEC SIPA1L2 FGD6 ARHGAP21 FBXW7 | 1.42e-07 | 692 | 174 | 22 | int:SFN |
| Interaction | HLA-B interactions | HLA-B HLA-C SH2D3C HLA-E HLA-F HLA-G MDN1 ADAM33 PRKN NCEH1 WDFY3 GPAT4 DOP1B | 1.67e-07 | 239 | 174 | 13 | int:HLA-B |
| Interaction | CAPZA2 interactions | WASHC2C PPP1R12A SPTBN1 SPTBN2 TRIOBP ITPRID2 PFKM WASHC2A CRACD INF2 EIF4B NINL MACF1 DLG4 PRKN PLEC ARHGAP21 | 2.07e-07 | 430 | 174 | 17 | int:CAPZA2 |
| Interaction | HLA-H interactions | 2.58e-07 | 17 | 174 | 5 | int:HLA-H | |
| Interaction | YWHAZ interactions | FOXO3 DSG2 PPP1R12A SPTBN1 SPTBN2 SH2D3C LAMC1 GIGYF1 ITPRID2 PFKM KRR1 ARHGEF16 NHSL1 CRACD KSR1 ADSL FAM86C1P TIAM1 EIF4B MACF1 DLG4 PRKN PRR14L EIF3A WDFY3 PLEC SIPA1L2 FGD6 ARHGAP21 PCNT FBXW7 | 3.09e-07 | 1319 | 174 | 31 | int:YWHAZ |
| Interaction | YWHAG interactions | FOXO3 DSG2 KRT19 PPP1R12A SPTBN1 DCP2 SH2D3C GIGYF1 ITPRID2 KRR1 ARHGEF16 NHSL1 CRACD KSR1 MDN1 FAM86C1P TIAM1 BAZ1A EIF4B SEC24B NINL MACF1 DLG4 PRKN SIPA1L2 FBXO45 FGD6 ARHGAP21 FBXW7 | 9.94e-07 | 1248 | 174 | 29 | int:YWHAG |
| Interaction | DUSP16 interactions | CCDC14 DYNC2H1 APAF1 ITPRID2 EIPR1 WASHC2A WDR35 EIF3A SIPA1L2 PCNT RGPD5 FBXW7 | 1.08e-06 | 237 | 174 | 12 | int:DUSP16 |
| Interaction | LILRB1 interactions | 1.08e-06 | 10 | 174 | 4 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 1.08e-06 | 10 | 174 | 4 | int:LILRB2 | |
| Interaction | KIF20A interactions | RGPD4 NRIP1 RANBP2 SETX RGPD8 DSG2 DYNC2H1 SYNE1 PPP1R12A SPTBN1 SPTBN2 APC2 EML6 ITPRID2 KRR1 TBL3 PHKG2 RGPD3 SEC24B NUP133 SMARCC2 PDZD8 MACF1 EIF3A PLEC HERC1 | 1.26e-06 | 1052 | 174 | 26 | int:KIF20A |
| Interaction | PCNT interactions | CCDC14 KRT19 SYNE1 SPTBN1 SPTBN2 SIRT7 WDR35 NINL MACF1 PLEC ARHGAP21 PCNT | 1.29e-06 | 241 | 174 | 12 | int:PCNT |
| Interaction | B2M interactions | 1.32e-06 | 92 | 174 | 8 | int:B2M | |
| Interaction | SYNE3 interactions | CCDC14 RANBP2 EMC1 HLA-C LAMC1 GIGYF1 ITPRID2 SEC24B SLMAP NUP133 PDZD8 MACF1 PLEC SIPA1L2 ARHGAP21 PCNT | 1.62e-06 | 444 | 174 | 16 | int:SYNE3 |
| Interaction | RGPD5 interactions | 1.83e-06 | 96 | 174 | 8 | int:RGPD5 | |
| Interaction | RGPD3 interactions | 3.04e-06 | 47 | 174 | 6 | int:RGPD3 | |
| Interaction | TOP3B interactions | FOXO3 PITPNM2 INPPL1 KHNYN SPTBN2 MYOM3 AKNA WASHC2A BIRC6 PLEKHM1 TBC1D9 NHSL1 THADA MDN1 INF2 PTPRS SEC24B PAXIP1 NINL LRP4 PDZD8 NLE1 PRKN WDFY3 PLEC ZNF324B HERC1 SIPA1L2 GPAT4 ARHGAP21 PCNT | 3.07e-06 | 1470 | 174 | 31 | int:TOP3B |
| Interaction | RGPD8 interactions | 3.51e-06 | 74 | 174 | 7 | int:RGPD8 | |
| Interaction | RGPD1 interactions | 3.91e-06 | 49 | 174 | 6 | int:RGPD1 | |
| Interaction | HLA-E interactions | 5.45e-06 | 79 | 174 | 7 | int:HLA-E | |
| Interaction | SASS6 interactions | 1.02e-05 | 159 | 174 | 9 | int:SASS6 | |
| Interaction | RAC1 interactions | RAB23 EMC1 HLA-B HLA-C DSG2 KRT19 INPPL1 SPTBN1 SPTBN2 TRIOBP PFKM PHKG2 MDN1 STXBP3 TIAM1 INF2 PTPRS LRP4 PDZD8 MACF1 DLG4 PRKN ARHGAP21 PACSIN2 | 1.54e-05 | 1063 | 174 | 24 | int:RAC1 |
| Interaction | DIRAS3 interactions | RAB23 DSG2 SPTBN1 SPTBN2 TIAM1 DCAF10 MACF1 HERC1 ARHGAP21 PACSIN2 BRMS1 | 1.81e-05 | 262 | 174 | 11 | int:DIRAS3 |
| Interaction | FGD4 interactions | 1.88e-05 | 64 | 174 | 6 | int:FGD4 | |
| Interaction | PRNP interactions | CCDC14 HLA-B CENPC DSG2 INPPL1 TRPS1 LAMC1 GIGYF1 KRR1 DCAF5 NHSL1 KSR1 THADA MDN1 ADSL INF2 EIF4B NLE1 MACF1 DLG4 IRF2BPL FBXO45 TNR FGD6 PACSIN2 | 2.13e-05 | 1158 | 174 | 25 | int:PRNP |
| Interaction | YWHAB interactions | FOXO3 EMC1 DSG2 PPP1R12A SPTBN1 GIGYF1 ITPRID2 KRR1 ARHGEF16 NHSL1 KSR1 FAM86C1P TIAM1 EIF4B NINL MACF1 DLG4 PRKN SIPA1L2 FBXO45 FGD6 ARHGAP21 FBXW7 | 2.19e-05 | 1014 | 174 | 23 | int:YWHAB |
| Interaction | DISC1 interactions | CWF19L2 EMC1 RGPD8 SYNE1 SPTBN1 ANGEL1 LAMC1 LRP4 MACF1 PRKN CCDC136 PCNT RGPD5 FBXW7 | 2.25e-05 | 429 | 174 | 14 | int:DISC1 |
| Interaction | CEP152 interactions | 2.62e-05 | 179 | 174 | 9 | int:CEP152 | |
| Interaction | RAC3 interactions | RAB23 EMC1 HLA-B HLA-C DSG2 SPTBN1 SPTBN2 TRIOBP STXBP3 PTPRS PDZD8 MACF1 PRKN GPAT4 SLC9A6 ARHGAP21 PACSIN2 | 2.72e-05 | 619 | 174 | 17 | int:RAC3 |
| Interaction | FKBP9P1 interactions | 3.43e-05 | 8 | 174 | 3 | int:FKBP9P1 | |
| Interaction | DDX11L8 interactions | 3.48e-05 | 22 | 174 | 4 | int:DDX11L8 | |
| Interaction | PFN1 interactions | RANBP2 INPPL1 SPTBN1 BIRC6 NHSL1 THADA INF2 SEC24B SLMAP MACF1 PRKN SIPA1L2 ARHGAP21 DOP1B PCNT | 3.72e-05 | 509 | 174 | 15 | int:PFN1 |
| Interaction | RHOB interactions | RAB23 HLA-B HLA-C DSG2 INPPL1 SPTBN1 SPTBN2 KIF16B TRIOBP ARHGEF16 MDN1 STXBP3 TIAM1 PTPRS LRP4 MACF1 HERC1 SIPA1L2 ARHGAP21 PACSIN2 | 4.01e-05 | 840 | 174 | 20 | int:RHOB |
| Interaction | ANKFY1 interactions | DSG2 KIF16B ARHGEF16 WASHC2A DCAF5 ADSL PRKN SIPA1L2 ARHGAP21 PCNT | 4.04e-05 | 236 | 174 | 10 | int:ANKFY1 |
| Interaction | PPP1CB interactions | PPP1R12A SPTBN1 SPTBN2 TRIOBP ITPRID2 SIRT7 INF2 EIF4B PPP1R16B DLG4 PRKN PLEC ARHGAP21 FBXW7 | 5.93e-05 | 469 | 174 | 14 | int:PPP1CB |
| Interaction | HLA-C interactions | EMC1 HLA-B HLA-C HLA-DRB3 SH2D3C HLA-E HLA-F HLA-G EXT2 ADAM33 PRKN FBXW7 | 5.96e-05 | 353 | 174 | 12 | int:HLA-C |
| Interaction | LNPK interactions | PITPNM2 EMC1 HLA-C DSG2 SYNE1 CHMP7 PHKG2 INF2 EIF4B SLMAP PDZD8 GPAT4 | 6.29e-05 | 355 | 174 | 12 | int:LNPK |
| Interaction | MYCBP2 interactions | RGPD8 PPP1R12A SPTBN1 SPTBN2 SIRT7 TBC1D9 MDN1 SMARCC2 MACF1 FBXO45 ARHGAP21 FBXW7 | 6.29e-05 | 355 | 174 | 12 | int:MYCBP2 |
| Interaction | TTLL5 interactions | 6.35e-05 | 49 | 174 | 5 | int:TTLL5 | |
| Interaction | MYO18A interactions | DSG2 PPP1R12A SPTBN1 SPTBN2 TRIOBP ITPRID2 CRACD INF2 PLEC ARHGAP21 FBXW7 | 6.79e-05 | 303 | 174 | 11 | int:MYO18A |
| Interaction | CD8A interactions | 6.92e-05 | 26 | 174 | 4 | int:CD8A | |
| Interaction | MYO19 interactions | DSG2 PPP1R12A SPTBN1 SPTBN2 ITPRID2 CRACD PHKG2 INF2 PLEC ARHGAP21 | 7.01e-05 | 252 | 174 | 10 | int:MYO19 |
| Interaction | VPS33A interactions | NRIP1 WASHC2C INPPL1 KIF16B TRIOBP BIRC6 PLEKHM1 ADSL INF2 NUP133 | 7.25e-05 | 253 | 174 | 10 | int:VPS33A |
| Interaction | DNAJC1 interactions | EMC1 HLA-C DSG2 SYNE1 KIF16B ITPRID2 CHMP7 INF2 SLMAP NUP133 PDZD8 FGG | 7.38e-05 | 361 | 174 | 12 | int:DNAJC1 |
| Interaction | RANBP2 interactions | RGPD4 RGPD2 CWF19L2 RANBP2 EMC1 RGPD8 PPP1R12A SIRT7 RGPD3 NUP133 PRKN RGPD5 | 7.38e-05 | 361 | 174 | 12 | int:RANBP2 |
| Interaction | RHOF interactions | RAB23 EMC1 HLA-B HLA-C DSG2 SPTBN1 SPTBN2 TRIOBP PFKM MDN1 STXBP3 TIAM1 INF2 MACF1 GPAT4 ARHGAP21 PACSIN2 | 7.68e-05 | 673 | 174 | 17 | int:RHOF |
| Interaction | AMOT interactions | CCDC14 WASHC2C KRT19 KIF16B MYOM3 WASHC2A BIRC6 SLMAP PRKN SIPA1L2 PCNT | 8.81e-05 | 312 | 174 | 11 | int:AMOT |
| Interaction | RANBP1 interactions | 9.38e-05 | 211 | 174 | 9 | int:RANBP1 | |
| Interaction | YWHAQ interactions | FOXO3 NRIP1 DSG2 KRT19 PPP1R12A GIGYF1 ITPRID2 KRR1 ARHGEF16 NHSL1 KSR1 FAM86C1P TIAM1 BAZ1A EIF4B MACF1 PRKN FGG PLEC SIPA1L2 FGD6 ARHGAP21 FBXW7 | 9.76e-05 | 1118 | 174 | 23 | int:YWHAQ |
| Interaction | DYNLL2 interactions | DYNC2H1 TRPS1 THAP10 NHSL1 INF2 SLMAP PAXIP1 DLG4 CCDC136 PCNT | 9.99e-05 | 263 | 174 | 10 | int:DYNLL2 |
| Interaction | HLA-F interactions | 1.01e-04 | 86 | 174 | 6 | int:HLA-F | |
| Interaction | RICTOR interactions | RGPD4 RGPD2 WASHC2C RGPD8 SPTBN1 TRPS1 WASHC2A PLEKHM1 CRYBB3 STXBP3 INF2 RGPD3 SEC24B NCEH1 EIF3A PLEC RGPD5 FBXW7 | 1.05e-04 | 759 | 174 | 18 | int:RICTOR |
| Interaction | RAB11A interactions | RAB23 DSG2 SPTBN1 KIF16B MUC19 KRR1 WASHC2A BIRC6 CHMP7 NOP14 INF2 SEC24B NUP133 LRP4 PDZD8 WDFY3 TIMM44 PACSIN2 DOP1B | 1.06e-04 | 830 | 174 | 19 | int:RAB11A |
| Interaction | ARMCX5 interactions | 1.08e-04 | 29 | 174 | 4 | int:ARMCX5 | |
| Interaction | ANXA3 interactions | 1.11e-04 | 55 | 174 | 5 | int:ANXA3 | |
| Interaction | INSYN1 interactions | 1.13e-04 | 169 | 174 | 8 | int:INSYN1 | |
| Interaction | GLDC interactions | DSG2 PPP1R12A SPTBN1 SPTBN2 ITPRID2 NOP14 SEC24B SMARCC2 EIF3A PLEC ARHGAP21 | 1.13e-04 | 321 | 174 | 11 | int:GLDC |
| Interaction | CLEC16A interactions | RANBP2 EMC1 HLA-C DSG2 DYNC2H1 ANGEL1 EIPR1 DCAF5 MDN1 DCAF10 NUP133 PRKN SIPA1L2 TIMM44 ARHGAP21 PACSIN2 | 1.16e-04 | 629 | 174 | 16 | int:CLEC16A |
| Interaction | RHOG interactions | RAB23 EMC1 HLA-B DSG2 SPTBN1 SPTBN2 APAF1 TRIOBP PFKM STXBP3 TIAM1 INF2 PDZD8 MACF1 PRKN TIMM44 GPAT4 ARHGAP21 PACSIN2 FBXW7 | 1.20e-04 | 910 | 174 | 20 | int:RHOG |
| Interaction | TNIK interactions | SYNE1 SPTBN1 SPTBN2 PTPRS SLMAP SMARCC2 MACF1 DLG4 PRKG1 FBXO45 TNR ARHGAP21 | 1.23e-04 | 381 | 174 | 12 | int:TNIK |
| Interaction | SYNE2 interactions | 1.24e-04 | 219 | 174 | 9 | int:SYNE2 | |
| Interaction | RHOJ interactions | RAB23 EMC1 HLA-B HLA-C DSG2 SPTBN1 SPTBN2 PFKM MDN1 STXBP3 TIAM1 PTPRS PDZD8 MACF1 ARHGAP21 PACSIN2 | 1.25e-04 | 633 | 174 | 16 | int:RHOJ |
| Interaction | ZNF563 interactions | 1.31e-04 | 12 | 174 | 3 | int:ZNF563 | |
| Interaction | RHOD interactions | RAB23 EMC1 HLA-B DSG2 SPTBN1 SPTBN2 TRIOBP MDN1 STXBP3 INF2 PDZD8 MACF1 GPAT4 ARHGAP21 PACSIN2 | 1.37e-04 | 572 | 174 | 15 | int:RHOD |
| Interaction | RHOH interactions | EMC1 HLA-C DSG2 SPTBN1 SPTBN2 TRIOBP PFKM CCNH MDN1 STXBP3 PTPRS PDZD8 PRKN PACSIN2 | 1.50e-04 | 512 | 174 | 14 | int:RHOH |
| Interaction | LAMP1 interactions | RAB23 EMC1 HLA-C DSG2 SPTBN1 SPTBN2 TRIOBP PLEKHM1 TIAM1 SEC24B SLC38A7 PDZD8 MACF1 GPAT4 ARHGAP21 PACSIN2 | 1.52e-04 | 644 | 174 | 16 | int:LAMP1 |
| Interaction | MAPRE1 interactions | RANBP2 PPP1R12A SPTBN1 APC2 ITPRID2 ARHGEF16 EIF4B NUP133 MACF1 EIF3A PLEC ARHGAP21 PCNT RGPD5 | 1.56e-04 | 514 | 174 | 14 | int:MAPRE1 |
| Interaction | IFI16 interactions | RGPD8 HLA-C SYNE1 ITPRID2 KRR1 TBL3 NOP14 CIITA INF2 EIF4B RGPD3 NUP133 SMARCC2 NLE1 PRKN EIF3A FBXW7 | 1.56e-04 | 714 | 174 | 17 | int:IFI16 |
| Interaction | S100P interactions | CCDC14 NRIP1 CWF19L2 ARSK KIF16B THAP10 FBXO9 SNAPC3 ARHGAP21 GABPA | 1.62e-04 | 279 | 174 | 10 | int:S100P |
| Interaction | CEP63 interactions | 1.68e-04 | 179 | 174 | 8 | int:CEP63 | |
| Interaction | LGI1 interactions | 1.68e-04 | 60 | 174 | 5 | int:LGI1 | |
| Interaction | CDC42 interactions | RAB23 EMC1 HLA-B HLA-C DSG2 DYNC2H1 SYNE1 PPP1R12A SPTBN1 SPTBN2 HLA-G PFKM ARHGEF16 THADA MDN1 STXBP3 TIAM1 INF2 PTPRS PDZD8 TMED9 PRKN GPAT4 ARHGAP21 PACSIN2 | 1.81e-04 | 1323 | 174 | 25 | int:CDC42 |
| Interaction | KALRN interactions | 1.85e-04 | 96 | 174 | 6 | int:KALRN | |
| Interaction | NUP88 interactions | 2.17e-04 | 140 | 174 | 7 | int:NUP88 | |
| Interaction | FAM86B1 interactions | 2.21e-04 | 3 | 174 | 2 | int:FAM86B1 | |
| Interaction | PRKCA interactions | WWC3 ADCY5 LDB3 TRNT1 CD5 STXBP3 TIAM1 EIF4B DLG4 PRKN PRKG1 FBXW7 | 2.31e-04 | 408 | 174 | 12 | int:PRKCA |
| Interaction | FMR1 interactions | RANBP2 CECR2 SPTBN1 APC2 SIRT7 SMARCC2 MACF1 DLG4 PRKN WDFY3 TNR ARHGAP21 PCNT FBXW7 | 2.39e-04 | 536 | 174 | 14 | int:FMR1 |
| Interaction | VASP interactions | WASHC2C DSG2 INPPL1 NHSL1 INF2 LRP4 PRKN PRKG1 SIPA1L2 ARHGAP21 | 2.47e-04 | 294 | 174 | 10 | int:VASP |
| Interaction | PTPRO interactions | 2.47e-04 | 143 | 174 | 7 | int:PTPRO | |
| Interaction | TFDP3 interactions | 2.55e-04 | 36 | 174 | 4 | int:TFDP3 | |
| Interaction | RAN interactions | RGPD4 RGPD2 RANBP2 RGPD8 INPPL1 BAZ1A RGPD3 NUP133 SMARCC2 PRKN PCNT RGPD5 FBXW7 | 2.56e-04 | 475 | 174 | 13 | int:RAN |
| Interaction | LAMP2 interactions | RAB23 WASHC2C DSG2 SPTBN1 SPTBN2 KIF16B WASHC2A PLEKHM1 TBC1D9 CHMP7 INF2 SLC38A7 PDZD8 NCEH1 DOP1B | 2.69e-04 | 609 | 174 | 15 | int:LAMP2 |
| Interaction | WDFY3 interactions | 2.72e-04 | 103 | 174 | 6 | int:WDFY3 | |
| Interaction | HLA-DRB3 interactions | 2.84e-04 | 67 | 174 | 5 | int:HLA-DRB3 | |
| Interaction | TEX9 interactions | 2.84e-04 | 37 | 174 | 4 | int:TEX9 | |
| Interaction | PANK2 interactions | 2.84e-04 | 37 | 174 | 4 | int:PANK2 | |
| Interaction | KLRD1 interactions | 2.87e-04 | 104 | 174 | 6 | int:KLRD1 | |
| Interaction | RNF123 interactions | RAB23 SETX KRT19 SPTBN2 HLA-G MYOM3 SLC5A7 MUC19 EVPL GRIK5 TEKT5 BIRC6 MDN1 INF2 PRKN EIF3A TNR DOP1B | 2.87e-04 | 824 | 174 | 18 | int:RNF123 |
| Interaction | CIT interactions | NRIP1 RANBP2 SETX HLA-C DSG2 DYNC2H1 SYNE1 PPP1R12A SPTBN1 SPTBN2 PFKM TEKT5 BIRC6 TBL3 NOP14 INF2 RGPD3 NUP133 SMARCC2 MACF1 DLG4 PRKN PRR14L EIF3A PLEC HERC1 | 3.02e-04 | 1450 | 174 | 26 | int:CIT |
| Interaction | LAMP3 interactions | RAB23 WASHC2C DSG2 SPTBN1 SPTBN2 KIF16B TBC1D9 CHMP7 MDN1 SEC24B LRP4 PDZD8 DOP1B | 3.19e-04 | 486 | 174 | 13 | int:LAMP3 |
| Interaction | ZNF816 interactions | 3.26e-04 | 16 | 174 | 3 | int:ZNF816 | |
| Interaction | TSC1 interactions | FOXO3 TRIOBP KANSL2 PTPRS SEC24B NINL TMED9 DLG4 EIF3A TNR FBXW7 | 3.51e-04 | 366 | 174 | 11 | int:TSC1 |
| Interaction | NUP43 interactions | RANBP2 SETX RGPD8 CENPC PPP1R12A MUC19 ITPRID2 TBL3 GPALPP1 NOP14 BAZ1A NUP133 PRKN GABPA RGPD5 | 3.54e-04 | 625 | 174 | 15 | int:NUP43 |
| Interaction | COMTD1 interactions | 3.55e-04 | 200 | 174 | 8 | int:COMTD1 | |
| Interaction | STX4 interactions | HLA-C DSG2 SYNE1 ITPRID2 CHMP7 STXBP3 INF2 SEC24B SLMAP NUP133 PDZD8 GPAT4 | 3.57e-04 | 428 | 174 | 12 | int:STX4 |
| Interaction | NCAPD3 interactions | 3.59e-04 | 152 | 174 | 7 | int:NCAPD3 | |
| Interaction | GAN interactions | 3.64e-04 | 253 | 174 | 9 | int:GAN | |
| Interaction | CDH1 interactions | HLA-C DSG2 INPPL1 SPTBN1 SPTBN2 EVPL ITPRID2 ARHGEF16 NHSL1 PTPRS EIF4B SEC24B LRATD2 MACF1 PLEC ARHGAP21 PACSIN2 | 3.66e-04 | 768 | 174 | 17 | int:CDH1 |
| Cytoband | 3q21.1 | 6.12e-05 | 20 | 177 | 3 | 3q21.1 | |
| GeneFamily | WD repeat domain containing | EML6 APAF1 WDR25 EIPR1 TBL3 DCAF5 DCAF10 WDR35 NLE1 WDFY3 HERC1 FBXW7 | 3.57e-07 | 262 | 128 | 12 | 362 |
| GeneFamily | C1-set domain containing | 4.76e-07 | 42 | 128 | 6 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 6.34e-07 | 44 | 128 | 6 | 588 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | SPTBN1 SPTBN2 TRIOBP ARHGEF16 PLEKHM1 TIAM1 ARHGAP25 FGD6 ARHGAP21 | 1.61e-05 | 206 | 128 | 9 | 682 |
| GeneFamily | EF-hand domain containing|Plakins | 1.89e-05 | 8 | 128 | 3 | 939 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.68e-04 | 115 | 128 | 6 | 769 | |
| GeneFamily | WASH complex | 7.32e-04 | 6 | 128 | 2 | 1331 | |
| GeneFamily | PDZ domain containing | 7.47e-04 | 152 | 128 | 6 | 1220 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.02e-03 | 7 | 128 | 2 | 1113 | |
| GeneFamily | Cyclins|F-boxes other | 2.63e-03 | 39 | 128 | 3 | 560 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 6.73e-09 | 39 | 175 | 7 | MM3725 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 5.16e-08 | 16 | 175 | 5 | MM3766 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 1.34e-07 | 59 | 175 | 7 | MM3704 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 1.35e-07 | 19 | 175 | 5 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 1.35e-07 | 19 | 175 | 5 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.79e-07 | 20 | 175 | 5 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 2.34e-07 | 21 | 175 | 5 | MM651 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 4.80e-07 | 24 | 175 | 5 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 5.97e-07 | 25 | 175 | 5 | MM672 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 1.85e-06 | 31 | 175 | 5 | MM3729 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.56e-06 | 33 | 175 | 5 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 2.73e-06 | 59 | 175 | 6 | MM3688 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 3.46e-06 | 35 | 175 | 5 | MM674 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 5.28e-06 | 142 | 175 | 8 | MM3757 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 6.00e-06 | 39 | 175 | 5 | MM3758 | |
| Coexpression | YU_MYC_TARGETS_DN | 6.31e-06 | 68 | 175 | 6 | MM632 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 6.48e-06 | 146 | 175 | 8 | MM856 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 7.73e-06 | 41 | 175 | 5 | MM710 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 8.47e-06 | 200 | 175 | 9 | M9041 | |
| Coexpression | RUAN_RESPONSE_TO_TROGLITAZONE_DN | 8.56e-06 | 20 | 175 | 4 | MM1288 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 9.55e-06 | 73 | 175 | 6 | M11428 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 9.82e-06 | 43 | 175 | 5 | MM1204 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 9.82e-06 | 43 | 175 | 5 | MM3857 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 1.10e-05 | 44 | 175 | 5 | MM3775 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 1.10e-05 | 44 | 175 | 5 | MM805 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 1.38e-05 | 46 | 175 | 5 | MM3712 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FOXO3 NRIP1 RANBP2 SETX CENPC PPP1R12A LAMC1 MDN1 STXBP3 TIAM1 BAZ1A SEC24B NUP133 MACF1 EIF3A WDFY3 DOP1B PCNT | 1.84e-05 | 856 | 175 | 18 | M4500 |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 1.87e-05 | 82 | 175 | 6 | MM3777 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 1.87e-05 | 82 | 175 | 6 | MM3858 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 1.88e-05 | 49 | 175 | 5 | MM1287 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RANBP2 SETX WWC3 HLA-B HLA-C CENPC SYNE1 PPP1R12A DCP2 TRPS1 SH2D3C HLA-E HLA-F AKNA BIRC6 DCAF5 CCNH CD5 BAZ1A EIF4B PPP1R16B MACF1 ARHGAP25 HERC1 GABPA | 2.06e-05 | 1492 | 175 | 25 | M40023 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 2.08e-05 | 50 | 175 | 5 | MM3805 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9 | 2.30e-05 | 85 | 175 | 6 | MM1279 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 2.46e-05 | 86 | 175 | 6 | MM834 | |
| Coexpression | HOLLERN_MICROACINAR_BREAST_TUMOR_UP | 2.53e-05 | 52 | 175 | 5 | MM968 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 2.53e-05 | 52 | 175 | 5 | MM3808 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 3.07e-05 | 132 | 175 | 7 | MM841 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 3.18e-05 | 90 | 175 | 6 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 3.63e-05 | 56 | 175 | 5 | MM3852 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 3.83e-05 | 93 | 175 | 6 | MM1185 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 3.96e-05 | 57 | 175 | 5 | MM3716 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE | NRIP1 WASHC2C GRIK5 KRR1 WASHC2A KSR1 CIITA SEC24B SLC38A7 PDZD8 EIF3A | 3.97e-05 | 368 | 175 | 11 | M41100 |
| Coexpression | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR | 4.31e-05 | 58 | 175 | 5 | MM661 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_MONOCYTE_PROGENITOR_CELL_AGEING | 4.86e-05 | 193 | 175 | 8 | MM3797 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | FOXO3 DSG2 KRT19 SPTBN1 LAMC1 EXT2 PTGFRN RSPRY1 EEF2KMT THADA FAM86C1P IRF2BPL NCEH1 WDFY3 PLEC ARHGAP21 RGPD5 | 5.33e-05 | 843 | 175 | 17 | M2356 |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 5.42e-05 | 196 | 175 | 8 | M3243 | |
| Coexpression | GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN | 6.25e-05 | 200 | 175 | 8 | M4878 | |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN | 6.25e-05 | 200 | 175 | 8 | M6185 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 6.80e-05 | 103 | 175 | 6 | MM476 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_PROMONOCYTE_AGEING | 7.18e-05 | 104 | 175 | 6 | MM3812 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NRIP1 EMC1 KRT19 SPTBN1 TRIOBP PTGFRN PHKG2 TIAM1 EIF4B LRATD2 PDZD8 SIPA1L2 | 7.60e-05 | 467 | 175 | 12 | M1347 |
| Coexpression | BILD_MYC_ONCOGENIC_SIGNATURE | 8.50e-05 | 209 | 175 | 8 | M2069 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 9.08e-05 | 211 | 175 | 8 | MM17081 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NRIP1 EMC1 KRT19 SPTBN1 TRIOBP PTGFRN PHKG2 TIAM1 EIF4B LRATD2 PDZD8 SIPA1L2 | 1.06e-04 | 484 | 175 | 12 | MM999 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | FOXO3 HLA-B HLA-C DSG2 KRT19 SPTBN1 HLA-E HLA-F TRIOBP LAMC1 ATP10B SERPINA6 PTGFRN ADCY5 BAZ1A LRATD2 MACF1 NCEH1 FGD6 ARHGAP21 PACSIN2 | 1.29e-04 | 1276 | 175 | 21 | M39173 |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | SETX HLA-B HLA-C SYNE1 PPP1R12A DCP2 SH2D3C HLA-E HLA-F AKNA CD5 EIF4B PPP1R16B MACF1 ARHGAP25 HERC1 FBXW7 | 1.36e-04 | 911 | 175 | 17 | M40038 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NRIP1 CWF19L2 SETX CENPC KIF16B KRR1 TBC1D9 GPALPP1 CCNH STXBP3 DCLRE1C BAZ1A SLMAP EIF3A | 1.39e-04 | 656 | 175 | 14 | M18979 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 1.39e-04 | 74 | 175 | 5 | MM3796 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 1.48e-04 | 75 | 175 | 5 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 1.48e-04 | 75 | 175 | 5 | MM3718 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 1.58e-04 | 120 | 175 | 6 | MM3710 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE | NRIP1 WASHC2C DSG2 GRIK5 ITPRID2 WASHC2A TBC1D9 KSR1 CIITA SLC38A7 MACF1 | 1.74e-04 | 435 | 175 | 11 | M41115 |
| Coexpression | BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN | 1.93e-04 | 43 | 175 | 4 | MM772 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | 2.06e-04 | 302 | 175 | 9 | MM1046 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 2.07e-04 | 126 | 175 | 6 | MM3711 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | PITPNM2 HLA-B HLA-C HLA-E HLA-F HLA-G CRACD NOP14 CLCA2 SEMA5B LRATD2 IRF2BPL GABPA | 2.08e-04 | 600 | 175 | 13 | MM1025 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 2.20e-04 | 240 | 175 | 8 | M39236 | |
| Coexpression | STOSSI_RESPONSE_TO_ESTRADIOL | 2.52e-04 | 46 | 175 | 4 | M11695 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 2.53e-04 | 84 | 175 | 5 | MM1049 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 2.89e-04 | 250 | 175 | 8 | M11318 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 2.97e-04 | 87 | 175 | 5 | MM652 | |
| Coexpression | PHESSE_TARGETS_OF_APC_AND_MBD2_UP | 3.07e-04 | 20 | 175 | 3 | MM890 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 3.14e-04 | 88 | 175 | 5 | MM1087 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_UP | 3.18e-04 | 192 | 175 | 7 | MM752 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 3.24e-04 | 137 | 175 | 6 | M39241 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 3.24e-04 | 137 | 175 | 6 | MM16612 | |
| Coexpression | FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP | 3.31e-04 | 89 | 175 | 5 | M6434 | |
| Coexpression | JONES_OVARY_NK_CELL | 3.31e-04 | 89 | 175 | 5 | M48353 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | EMC1 HLA-B HLA-C TRPS1 HLA-E HLA-F HLA-G LAMC1 PTPRS NCEH1 BRMS1 | 3.38e-04 | 470 | 175 | 11 | MM1053 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 3.48e-04 | 90 | 175 | 5 | MM3756 | |
| Coexpression | GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP | 3.60e-04 | 196 | 175 | 7 | M3203 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BASOPHIL_UP | 3.60e-04 | 196 | 175 | 7 | M5413 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_ASTROCYTE_AGEING | PITPNM2 HLA-B HLA-C INPPL1 HLA-E HLA-F HLA-G TMED9 IRF2BPL WDFY3 SLC9A6 | 3.62e-04 | 474 | 175 | 11 | MM3685 |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING | 3.64e-04 | 140 | 175 | 6 | MM3705 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 3.66e-04 | 91 | 175 | 5 | MM3720 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 3.72e-04 | 197 | 175 | 7 | M7543 | |
| Coexpression | GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP | 3.83e-04 | 198 | 175 | 7 | M8423 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 3.85e-04 | 92 | 175 | 5 | MM3748 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ATRIAL_MYOCYTE_AGEING | 3.93e-04 | 142 | 175 | 6 | MM3703 | |
| Coexpression | GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 3.95e-04 | 199 | 175 | 7 | M312 | |
| Coexpression | GSE27786_NKTCELL_VS_ERYTHROBLAST_UP | 3.95e-04 | 199 | 175 | 7 | M4865 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 3.95e-04 | 199 | 175 | 7 | M6028 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 3.95e-04 | 199 | 175 | 7 | M5486 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_DN | 3.96e-04 | 262 | 175 | 8 | M11472 | |
| Coexpression | CAMPS_COLON_CANCER_COPY_NUMBER_UP | 4.05e-04 | 93 | 175 | 5 | M18750 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN | 4.07e-04 | 200 | 175 | 7 | M8106 | |
| Coexpression | GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 4.07e-04 | 200 | 175 | 7 | M300 | |
| Coexpression | GSE27786_NKTCELL_VS_NEUTROPHIL_UP | 4.07e-04 | 200 | 175 | 7 | M4868 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP | 4.07e-04 | 200 | 175 | 7 | M3404 | |
| Coexpression | GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN | 4.07e-04 | 200 | 175 | 7 | M4793 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CWF19L2 RANBP2 SETX HLA-C CENPC EML6 KRR1 BIRC6 KSR1 NOP14 ADSL KCNT2 SEMA5B BAZ1A PAXIP1 NINL LRP4 EIF3A PCNT | 8.35e-08 | 532 | 174 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OSK-L-l-p53KD-Confounder_removed-fold2.0_adjp0.05 | 5.41e-07 | 3 | 174 | 3 | PCBC_ratio_ESC_vs_iPSC_method-OSK-L-l-p53KD_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 4.87e-05 | 204 | 174 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | SC blastocyst_vs_SC amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 5.66e-05 | 26 | 174 | 4 | PCBC_ratio_SC blastocyst_vs_SC amniotic fluid MSC_cfr-2X-p05 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.11e-08 | 196 | 176 | 9 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 1.08e-07 | 200 | 176 | 9 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 6.98e-07 | 183 | 176 | 8 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.08e-06 | 194 | 176 | 8 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.17e-06 | 196 | 176 | 8 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8|bone_marrow / Manually curated celltypes from each tissue | 1.17e-06 | 196 | 176 | 8 | 5c9ed3c6e3cbd43b52f0291b5c26dd7f9fadf3da | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-06 | 196 | 176 | 8 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.17e-06 | 196 | 176 | 8 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 1.17e-06 | 196 | 176 | 8 | 2bf0f36af1d0934c03999dbbff3c51ae9432386d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.22e-06 | 197 | 176 | 8 | 2b3a56bb1d40bc1284a5931c4e7b373660de5402 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class | 1.22e-06 | 197 | 176 | 8 | f0bac4d5c3160933ac3786cec8dadffb35d711ea | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.22e-06 | 197 | 176 | 8 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.22e-06 | 197 | 176 | 8 | f73ece3aca28c0db5db0f12e026d42c6c36b9efb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-06 | 197 | 176 | 8 | e70e7d97823a762def3970d94a0e897981a6c922 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-06 | 197 | 176 | 8 | bce0135a96910d2bace62a3408a1a6fdac0cf0df | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.36e-06 | 200 | 176 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Severe / Disease, condition lineage and cell class | 1.36e-06 | 200 | 176 | 8 | 31859b8db7ea17e48b7b54e92f0d76aeb755e7ca | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-06 | 155 | 176 | 7 | 98d8432739965dd1ab77c899cb6321f7f05eaa46 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.36e-06 | 159 | 176 | 7 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 164 | 176 | 7 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 164 | 176 | 7 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 164 | 176 | 7 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.65e-06 | 167 | 176 | 7 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.43e-06 | 171 | 176 | 7 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-06 | 176 | 176 | 7 | ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-06 | 186 | 176 | 7 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.41e-06 | 186 | 176 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.01e-05 | 188 | 176 | 7 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-05 | 190 | 176 | 7 | 55df73c8b696967a925b1772631f6900eff0fa30 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-05 | 190 | 176 | 7 | 494fbab37305a7f92cddec75b291d42282555f5f | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 192 | 176 | 7 | 4098b5170c9995718758a082d1b8bcb86d5a289e | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 192 | 176 | 7 | 936028fe851e8dd2b906df0210acc574c017b499 | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 192 | 176 | 7 | 62e55ed0d46b2e7b07dc42399972a099576cbc5f | |
| ToppCell | 367C-Lymphocytic|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 193 | 176 | 7 | b069a1cba2e1bf1c0d7479b11185fb416f18b14b | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 193 | 176 | 7 | 22ebc3f586eb0aabc5785e468c88d7416c624ff4 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.20e-05 | 193 | 176 | 7 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | Healthy_donor-CD8+_Tem|Healthy_donor / disease group, cell group and cell class (v2) | 1.24e-05 | 194 | 176 | 7 | bf2e889de60b2b452a41f4d59a0f2a1865f07184 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 194 | 176 | 7 | 9344556b375fd9267652cdca57b2cbd50a878a1e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.24e-05 | 194 | 176 | 7 | 95ab357d5f7bf91ba287417928c8575e655814fc | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 194 | 176 | 7 | bf7bf75bbc2035be25d3605e6a1a59e6bc573be7 | |
| ToppCell | (1)_T_CD8_CTL|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.28e-05 | 195 | 176 | 7 | f582b854e5a4c52764aad5abe4e28ea77a7445f7 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 195 | 176 | 7 | 073593a7f668512d1fbbb49efb0c20b736c79ff8 | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 1.28e-05 | 195 | 176 | 7 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | normal_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.28e-05 | 195 | 176 | 7 | 3af8ea15e2ac8efdeb4d4f69357b83b8dbcfab8d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm/em_CD8|bone_marrow / Manually curated celltypes from each tissue | 1.28e-05 | 195 | 176 | 7 | ed4e2275dac47cc9fb9c381e3f80fed0ce50b074 | |
| ToppCell | Healthy/Control-CD8+_Tem|Healthy/Control / Disease group and Cell class | 1.28e-05 | 195 | 176 | 7 | f4955c176c4918052dc151c5e5249223ec428272 | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.28e-05 | 195 | 176 | 7 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 195 | 176 | 7 | 6774c9f7fa54045aaa35fbd0695e43748da2b293 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.28e-05 | 195 | 176 | 7 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.28e-05 | 195 | 176 | 7 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.28e-05 | 195 | 176 | 7 | 1a7c2c4cf30df435770794a989be438579bf98f2 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.32e-05 | 196 | 176 | 7 | 91902e135c05d1214d915c8d8e6037929c2501b8 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.32e-05 | 196 | 176 | 7 | 5cc14a5797884ff3a007683048e690a0d7172fc4 | |
| ToppCell | severe-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.32e-05 | 196 | 176 | 7 | d83acd9abd7b296989b8ae09da63799e6877a149 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.32e-05 | 196 | 176 | 7 | 07e6214e771c65574f0ada65e75f4bda265aa47f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 1.32e-05 | 196 | 176 | 7 | f23c33ad10f933250be98e8389a9aa278e876f96 | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.32e-05 | 196 | 176 | 7 | d074c24fecd0e3ffca4699fb1a9d443e6d9a858d | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.32e-05 | 196 | 176 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Healthy_donor-CD4+_CTL|Healthy_donor / disease group, cell group and cell class (v2) | 1.37e-05 | 197 | 176 | 7 | 48592619b4d6cd1898ed1c2d1d447193efad9efa | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 1.37e-05 | 197 | 176 | 7 | 13e6611cde9364f0c1bf681b0b26c4d2725e5f4a | |
| ToppCell | mild-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.37e-05 | 197 | 176 | 7 | 8b0e4012e25641c3bcd3e9911031e43d9dbbff21 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 1.37e-05 | 197 | 176 | 7 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | (1)_T_CD8_CytT|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.37e-05 | 197 | 176 | 7 | 804cec3b1839562dc027a5a2a1e015919bd31de7 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.37e-05 | 197 | 176 | 7 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.37e-05 | 197 | 176 | 7 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD8-Tem/emra_CD8|Liver / Manually curated celltypes from each tissue | 1.41e-05 | 198 | 176 | 7 | 2fc2a4638c458ae793ac090a29d27b75fc9e6af6 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.41e-05 | 198 | 176 | 7 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.41e-05 | 198 | 176 | 7 | 1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d | |
| ToppCell | mild_COVID-19-CD8+_Tem|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.41e-05 | 198 | 176 | 7 | 12847340c36a6791d8bdcb81e731e2fdeec46326 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.46e-05 | 199 | 176 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.46e-05 | 199 | 176 | 7 | 72c96a5954dfcfbfee8f095984ce1f5249d9a679 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 199 | 176 | 7 | 5d976d57872a8a25a11fe8cd53b01aa21a1a519a | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.46e-05 | 199 | 176 | 7 | db05c16d80f5a74bfa048a5c92917d312d26f769 | |
| ToppCell | COVID-19_Moderate-CD4+_CTL|World / disease group, cell group and cell class | 1.46e-05 | 199 | 176 | 7 | 12ea0346b4da3e8e2b3b2b3b3e9d4f4f104345a6 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.46e-05 | 199 | 176 | 7 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 200 | 176 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.51e-05 | 200 | 176 | 7 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-05 | 200 | 176 | 7 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 200 | 176 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 200 | 176 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | severe-CD8+_Tem|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.51e-05 | 200 | 176 | 7 | aaa2cd326dc15dee2fd975ca133359c5826f6a75 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD4+_CTL|ICU-NoSEP / Disease, condition lineage and cell class | 1.51e-05 | 200 | 176 | 7 | c470520ce77130811fdc2a1d3d796d8836275de1 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.51e-05 | 200 | 176 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.63e-05 | 135 | 176 | 6 | 451e90c154e26ae4f72269d6765e7ef51d67313a | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.35e-05 | 144 | 176 | 6 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.84e-05 | 149 | 176 | 6 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.55e-05 | 155 | 176 | 6 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_CTL|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.54e-05 | 162 | 176 | 6 | d53de64df2511eddba79f899fc3f48b1b059923f | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.03e-05 | 165 | 176 | 6 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-05 | 167 | 176 | 6 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.13e-05 | 171 | 176 | 6 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.13e-05 | 171 | 176 | 6 | d6d8ea45b443d95f64720c9bc07d324148f5b239 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.13e-05 | 171 | 176 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.13e-05 | 171 | 176 | 6 | 6be81c20f4e962b414afcedfe478dd59c510d1e1 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.54e-05 | 173 | 176 | 6 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.97e-05 | 175 | 176 | 6 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B1|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.97e-05 | 175 | 176 | 6 | b1003230c39b2a9ceb43cb80728061d906ed0835 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.42e-05 | 177 | 176 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.66e-05 | 178 | 176 | 6 | 375c9449be570b4aed83611f9c6fe1665e677818 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_C|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.66e-05 | 178 | 176 | 6 | 7203149864cc8d5ae25329fdbf15c6b73c3d3595 | |
| Computational | Genes in the cancer module 293. | 6.36e-08 | 12 | 106 | 5 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 1.58e-07 | 14 | 106 | 5 | MODULE_143 | |
| Computational | Neighborhood of PTPN6 | 6.17e-06 | 47 | 106 | 6 | GNF2_PTPN6 | |
| Computational | Neighborhood of VAV1 | 2.51e-05 | 36 | 106 | 5 | GNF2_VAV1 | |
| Computational | Neighborhood of INPP5D | 6.06e-05 | 43 | 106 | 5 | GNF2_INPP5D | |
| Computational | Neighborhood of HLA-C | 9.36e-05 | 47 | 106 | 5 | GNF2_HLA_C | |
| Computational | Neighborhood of CD53 | 2.57e-04 | 58 | 106 | 5 | GNF2_CD53 | |
| Computational | Neighborhood of CD48 | 2.60e-04 | 32 | 106 | 4 | GNF2_CD48 | |
| Computational | Neighborhood of PTPRC | 5.40e-04 | 68 | 106 | 5 | GNF2_PTPRC | |
| Computational | Neighborhood of ICAM3 | 5.63e-04 | 39 | 106 | 4 | GNF2_ICAM3 | |
| Computational | Neighborhood of STAT6 | 1.07e-03 | 79 | 106 | 5 | GNF2_STAT6 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.35e-03 | 49 | 106 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.45e-03 | 50 | 106 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Drug | plakin | 3.29e-06 | 82 | 175 | 7 | CID000018752 | |
| Drug | tert-butyl acetate | 5.50e-06 | 58 | 175 | 6 | CID000010908 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.01e-10 | 7 | 163 | 5 | DOID:0081267 (implicated_via_orthology) | |
| Disease | serum albumin measurement | HLA-B TRPS1 GRIK5 SERPINA6 PLEKHM1 PHKG2 KCNT2 CATSPER2 SEMA5B CIITA MACF1 DLG4 IRF2BPL PLEC PCNT | 1.13e-06 | 592 | 163 | 15 | EFO_0004535 |
| Disease | Disproportionate short stature | 4.44e-06 | 77 | 163 | 6 | C0878659 | |
| Disease | brain measurement, neuroimaging measurement | FOXO3 FAT3 SPTBN1 TRPS1 TRIOBP LAMC1 CHMP7 NHSL1 THADA SLC38A7 MACF1 PLEC FGD6 | 1.26e-05 | 550 | 163 | 13 | EFO_0004346, EFO_0004464 |
| Disease | monocyte count | NRIP1 HLA-B HLA-C CECR2 PPP1R12A HLA-DRB3 SPTBN1 SPTBN2 TRPS1 SH2D3C PTGFRN ADCY5 PLEKHM1 CHMP7 KSR1 THADA ADSL CIITA BAZ1A CD226 ARHGAP25 | 1.34e-05 | 1320 | 163 | 21 | EFO_0005091 |
| Disease | cortical thickness | FOXO3 PITPNM2 HTR1D HLA-B FAT3 SPTBN1 SPTBN2 TRPS1 TRIOBP LAMC1 PLEKHM1 CHMP7 NHSL1 THADA BAZ1A LRP4 MACF1 PLEC ARHGAP21 | 1.35e-05 | 1113 | 163 | 19 | EFO_0004840 |
| Disease | platelet component distribution width | FOXO3 NRIP1 HLA-B SYNE1 KIF16B ADCY5 DCAF5 CD226 PPP1R16B MACF1 ADAM33 PLEC HERC1 FGD6 PACSIN2 | 2.08e-05 | 755 | 163 | 15 | EFO_0007984 |
| Disease | immature platelet measurement | 5.37e-05 | 119 | 163 | 6 | EFO_0803541 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.81e-04 | 4 | 163 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | glycogen storage disease (implicated_via_orthology) | 1.81e-04 | 4 | 163 | 2 | DOID:2747 (implicated_via_orthology) | |
| Disease | occupational asthma (is_implicated_in) | 1.81e-04 | 4 | 163 | 2 | DOID:0080820 (is_implicated_in) | |
| Disease | monocyte percentage of leukocytes | NRIP1 HLA-B HLA-C CECR2 TRPS1 SH2D3C ADCY5 CHMP7 KSR1 THADA CIITA ARHGAP25 WDFY3 | 2.24e-04 | 731 | 163 | 13 | EFO_0007989 |
| Disease | allergic asthma (is_implicated_in) | 3.00e-04 | 5 | 163 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | Short rib-polydactyly syndrome, Verma-Naumoff type | 3.00e-04 | 5 | 163 | 2 | C0432197 | |
| Disease | neuroimaging measurement | FOXO3 HTR1D FAT3 SPTBN1 TRPS1 THAP10 LAMC1 CHMP7 NHSL1 THADA BAZ1A SLMAP NINL MACF1 PLEC FGD6 | 3.00e-04 | 1069 | 163 | 16 | EFO_0004346 |
| Disease | Myasthenic Syndromes, Congenital | 3.08e-04 | 24 | 163 | 3 | C0751882 | |
| Disease | immature platelet fraction | 4.37e-04 | 114 | 163 | 5 | EFO_0009187 | |
| Disease | glucagon measurement, glucose tolerance test | 4.48e-04 | 6 | 163 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | artificially sweetened beverage consumption measurement | 4.48e-04 | 6 | 163 | 2 | EFO_0010096 | |
| Disease | angina pectoris | 6.65e-04 | 125 | 163 | 5 | EFO_0003913 | |
| Disease | reticulocyte count | FOXO3 PITPNM2 HLA-C TRPS1 EML6 HLA-G PFKM BIRC6 GPALPP1 THADA DCAF10 BAZ1A CD226 ADAM33 HERC1 | 7.15e-04 | 1045 | 163 | 15 | EFO_0007986 |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.06e-03 | 9 | 163 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine | 1.12e-03 | 37 | 163 | 3 | EFO_0004276, EFO_0004775, EFO_0006997 | |
| Disease | cortical surface area measurement | FOXO3 PITPNM2 HTR1D HLA-B FAT3 SPTBN1 KHNYN TRIOBP LAMC1 PLEKHM1 CHMP7 NHSL1 THADA MACF1 PRKG1 FGD6 ARHGAP21 | 1.29e-03 | 1345 | 163 | 17 | EFO_0010736 |
| Disease | eosinophil count | NRIP1 HLA-B HLA-C HLA-DRB3 SPTBN1 HLA-G GRIK5 GIGYF1 PTGFRN THADA CD5 MDN1 CIITA CD226 NUP133 LRATD2 PLEC FBXW7 | 1.52e-03 | 1488 | 163 | 18 | EFO_0004842 |
| Disease | alkaline phosphatase measurement | EMC1 SPTBN1 KIF16B GRIK5 ADCY5 PLEKHM1 ADSL CATSPER2 MACF1 DLG4 SLC16A11 ARHGAP25 PRR14L ARHGAP21 | 1.56e-03 | 1015 | 163 | 14 | EFO_0004533 |
| Disease | complement C1q tumor necrosis factor-related protein 5 measurement | 1.61e-03 | 11 | 163 | 2 | EFO_0801494 | |
| Disease | beta-2 microglobulin measurement | 1.61e-03 | 11 | 163 | 2 | EFO_0005197 | |
| Disease | neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, obsolete_red blood cell distribution width, basophil count, platelet count, eosinophil count | 1.61e-03 | 11 | 163 | 2 | EFO_0004305, EFO_0004308, EFO_0004309, EFO_0004526, EFO_0004528, EFO_0004584, EFO_0004833, EFO_0004842, EFO_0005090, EFO_0005091, EFO_0005192 | |
| Disease | neutrophil count | WASHC2C HLA-B HLA-C DYNC2H1 HLA-DRB3 SPTBN1 EML6 HLA-G PTGFRN THADA ADSL CD226 SLMAP LRP4 ARHGAP25 TNR PCNT | 1.72e-03 | 1382 | 163 | 17 | EFO_0004833 |
| Disease | asthma (is_implicated_in) | 1.84e-03 | 157 | 163 | 5 | DOID:2841 (is_implicated_in) | |
| Disease | dermatomyositis | 1.93e-03 | 12 | 163 | 2 | EFO_0000398 | |
| Disease | Short Rib-Polydactyly Syndrome | 2.27e-03 | 13 | 163 | 2 | C0036996 | |
| Disease | brain cortex volume measurement | 2.27e-03 | 13 | 163 | 2 | EFO_0010287 | |
| Disease | Major Depressive Disorder | 2.38e-03 | 243 | 163 | 6 | C1269683 | |
| Disease | mitochondrial DNA measurement | 2.39e-03 | 328 | 163 | 7 | EFO_0006312 | |
| Disease | Malignant neoplasm of breast | NRIP1 DYNC2H1 SYNE1 APC2 KIF16B CCNH KCNT2 CLCA2 SEMA5B NUP133 NLE1 MACF1 ADAM33 FBXW7 | 2.62e-03 | 1074 | 163 | 14 | C0006142 |
| Disease | Saldino-Noonan Syndrome | 2.64e-03 | 14 | 163 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 2.64e-03 | 14 | 163 | 2 | C0024507 | |
| Disease | immature platelet count | 2.88e-03 | 106 | 163 | 4 | EFO_0803544 | |
| Disease | complement C4 measurement | 3.00e-03 | 52 | 163 | 3 | EFO_0004984 | |
| Disease | Drugs used in diabetes use measurement | 3.02e-03 | 255 | 163 | 6 | EFO_0009924 | |
| Disease | liver neoplasm | 3.04e-03 | 15 | 163 | 2 | EFO_1001513 | |
| Disease | severe aplastic anemia | 3.04e-03 | 15 | 163 | 2 | EFO_0006927 | |
| Disease | HSV2 virologic severity measurement | 3.04e-03 | 15 | 163 | 2 | EFO_0009010 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 3.04e-03 | 15 | 163 | 2 | EFO_0801746 | |
| Disease | Unipolar Depression | 3.26e-03 | 259 | 163 | 6 | C0041696 | |
| Disease | serum alanine aminotransferase measurement | FOXO3 NRIP1 HLA-DRB3 PKD1L1 TRPS1 KIF16B AKNA SERPINA6 DCAF5 TRMT44 SLC38A7 PRKN | 3.33e-03 | 869 | 163 | 12 | EFO_0004735 |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 3.46e-03 | 16 | 163 | 2 | C0751885 | |
| Disease | 5-oxoproline measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0010988 | |
| Disease | gastroparesis | 3.46e-03 | 16 | 163 | 2 | EFO_1000948 | |
| Disease | free cholesterol measurement | 3.62e-03 | 113 | 163 | 4 | EFO_0008591 | |
| Disease | stroke outcome severity measurement | 3.74e-03 | 114 | 163 | 4 | EFO_0009603 | |
| Disease | Glycogen storage disease | 3.91e-03 | 17 | 163 | 2 | cv:C0017919 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 3.91e-03 | 17 | 163 | 2 | C0751883 | |
| Disease | major depressive disorder (is_marker_for) | 3.91e-03 | 17 | 163 | 2 | DOID:1470 (is_marker_for) | |
| Disease | Moyamoya Disease | 3.91e-03 | 17 | 163 | 2 | C0026654 | |
| Disease | lymphocyte measurement | 4.10e-03 | 117 | 163 | 4 | EFO_0803546 | |
| Disease | sweet liking measurement | 4.38e-03 | 18 | 163 | 2 | EFO_0010156 | |
| Disease | age at onset, Parkinson disease | 4.38e-03 | 18 | 163 | 2 | EFO_0004847, MONDO_0005180 | |
| Disease | mean platelet volume | PITPNM2 HLA-B HLA-C SPTBN1 EML6 KIF16B DCAF5 CD226 PPP1R16B ZNF778 PLEC ZNF324B PACSIN2 | 4.47e-03 | 1020 | 163 | 13 | EFO_0004584 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.62e-03 | 121 | 163 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | disease progression measurement | 4.71e-03 | 61 | 163 | 3 | EFO_0008336 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 4.88e-03 | 19 | 163 | 2 | C0751884 | |
| Disease | hepatitis B virus infection | 4.88e-03 | 19 | 163 | 2 | EFO_0004197 | |
| Disease | cleft lip | 5.09e-03 | 284 | 163 | 6 | EFO_0003959 | |
| Disease | neuroimaging measurement, brain volume measurement | 5.26e-03 | 286 | 163 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 5.40e-03 | 20 | 163 | 2 | DOID:3328 (is_marker_for) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.48e-03 | 127 | 163 | 4 | EFO_0008595, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFLTSSDDQTIRLWE | 896 | O14727 | |
| HSISNRVEAWTRDVA | 136 | Q6UWY0 | |
| RRESSTWANEVEDRR | 111 | P0DMU3 | |
| WTFSSEEQLARLRAD | 11 | P51946 | |
| AEWSRSNLDTEVTTA | 2296 | Q9NR09 | |
| SSESRFSESIGRLDW | 456 | Q96P56 | |
| RAALSDTVALWESLQ | 886 | P33076 | |
| SSDSASDRARWIVAL | 601 | Q5VV41 | |
| CDSSSARSSLRWEEV | 301 | P06127 | |
| EVWTERDRSRVTQDA | 261 | Q9BZ11 | |
| RDRSRVTQDANATLW | 266 | Q9BZ11 | |
| RDWLSRRFGDSSDSD | 236 | Q8IU60 | |
| QQRLASRWRSDDDDD | 66 | O95622 | |
| RSERDTSDLEQNWSL | 181 | Q49A88 | |
| EEWRQVTESFRERTS | 251 | Q9BXF3 | |
| RWASFRREAEASLDN | 851 | O94823 | |
| TVLDRWRESLLSSAS | 1111 | Q9NRL2 | |
| SRINETTRWDEASFR | 131 | Q96L93 | |
| AERNIALRSSLEWNS | 191 | P49792 | |
| LESDKSDWRATNTDL | 221 | P49792 | |
| TTDRESFEAVSSWRE | 91 | Q9ULC3 | |
| AERNIALRSSLEWNS | 191 | Q99666 | |
| AERNIALRSSLEWNS | 191 | O14715 | |
| LESDKSDWRATNTDL | 221 | O14715 | |
| SLNEDLRSWTAADTV | 146 | P30511 | |
| LEDRDNWISVDSVTS | 431 | Q14126 | |
| NEDLRSWTAADTAAQ | 151 | P17693 | |
| LSQVSSEDRSALWAL | 106 | Q6ZW49 | |
| TSQFTTRDDILRDWN | 451 | P19113 | |
| DLTLSSVLWDRERSS | 271 | Q8WUM0 | |
| WQSLEAKLRDSSDSE | 31 | P0C5J1 | |
| WDRETRSARDTAQIF | 81 | P13747 | |
| TLNEDLRSWTAVDTA | 146 | P13747 | |
| DRSAQDTAWISALAL | 71 | Q8NCK7 | |
| EQNRKDAEAWFTSRT | 261 | P08727 | |
| DAEAWFTSRTEELNR | 266 | P08727 | |
| EADSRLLTEISSSWD | 4176 | Q9NU22 | |
| ARSDSENWRSLREEQ | 191 | O75420 | |
| DEWARRSSNLQSRSF | 261 | O75112 | |
| ERSREFSWSERNVSL | 1661 | Q4ZG55 | |
| SEQATVDAWLQRSSS | 151 | Q9UKN7 | |
| SDETSEQVTRWAAAL | 156 | Q06546 | |
| LWTILRDRGSFEDST | 446 | Q13976 | |
| RNFESSSEWADLISS | 26 | Q9Y3R5 | |
| WQSLEAKLRDSSDSE | 31 | Q9NVL1 | |
| IQTRSSSRDRWISEN | 1316 | Q15751 | |
| SSRDRWISENQDSAD | 1321 | Q15751 | |
| EALARWEAAATESTR | 141 | A0A1B0GVG4 | |
| WEAAATESTRRLDEA | 146 | A0A1B0GVG4 | |
| RKAVSNLDEESRWTV | 66 | Q5SYE7 | |
| WQSLEAKLRDSSDSE | 31 | Q8N7N1 | |
| NEDLRSWTAADTAAQ | 151 | P10321 | |
| ELSESLRNRAEEWAS | 356 | Q9H1B7 | |
| EHKEDSSWSSLDARR | 176 | Q8IVT5 | |
| SRERWDAGNSRSEDS | 171 | Q7Z5P9 | |
| DSSDDRQTWESSEIL | 671 | Q8NEN9 | |
| DTFRSEWSDLLSDLQ | 126 | P08237 | |
| VEEAAAVRARLNWTS | 276 | Q6PIU2 | |
| NSEERLTSWSRSDGR | 411 | Q2TBE0 | |
| WQSLEAKLRDSSDSE | 31 | Q96G04 | |
| RAETLGRTWSREESE | 1566 | Q92817 | |
| ATCSDDTTIALWDLR | 226 | Q5QP82 | |
| WRDLDARITDTANES | 216 | Q96JB1 | |
| SLVRREIEGWSSDSD | 421 | Q96JK2 | |
| SGRELIENSRDDTTW | 2851 | O94854 | |
| SRETQDKDIWREASS | 1081 | P48552 | |
| RELAKDSELRSQSWE | 226 | Q13601 | |
| AKERELSWRNSESFA | 191 | Q96KN1 | |
| WDTLRRNTSQALFSD | 311 | Q86XE3 | |
| DRTSSDHQTILRAWA | 391 | Q6UVM3 | |
| SEWRMQSIARDSDES | 326 | Q9BZ72 | |
| SAREDVATWQQSSLS | 651 | P78316 | |
| NEDLRSWTAADTAAQ | 151 | P01889 | |
| RSSWQASETEDLSTE | 31 | P28290 | |
| WSQLDSARTSRQELS | 471 | O95613 | |
| EWDDRSSTVKDLISR | 256 | P15735 | |
| VATANDTTLRGWDTR | 201 | Q53HC9 | |
| LDATTASESRGWDLV | 1036 | Q27J81 | |
| IQSLASSRTDRDAWQ | 1071 | Q9UPN3 | |
| SSRTDRDAWQDNALR | 1076 | Q9UPN3 | |
| LRAEARSETSITLSW | 531 | Q13332 | |
| AILWQRSAAEDQRTS | 366 | Q96T49 | |
| WDSDSALSEENESRR | 91 | P78367 | |
| FEEWSADLNRTLSRR | 301 | Q9UNF0 | |
| AERNIALRSSLEWNS | 191 | A6NKT7 | |
| LESDKSDWRATNTDL | 221 | A6NKT7 | |
| ALRVELEDWNGRTST | 271 | P02679 | |
| WDEADVRFSSQNRKS | 56 | P57057 | |
| DDWSRDIQSGLSDSR | 536 | Q8NCM8 | |
| SALTVEWRARSESAQ | 211 | P79483 | |
| NLSARSARDQELLWD | 651 | O95996 | |
| DRASDLDSVEWRAIQ | 1676 | O95996 | |
| RKRSWSSEEESNQAT | 121 | Q8NFZ0 | |
| WDSQSDTVLLSSQER | 551 | Q96SD1 | |
| RSEREEVSSWRRADD | 1301 | Q14152 | |
| SAEELESWNLLSRTN | 136 | Q86UL3 | |
| DESDQSFASRSWITI | 306 | Q03188 | |
| SEVWRSLCARSLAEE | 76 | P0C2W1 | |
| RWVVSSDLDLRSLEQ | 201 | Q9UK97 | |
| SAFKRSREVNSTDWD | 36 | Q8WUX9 | |
| SASALAEWASIRSRI | 661 | Q6ZU35 | |
| AWSNSRDSDSLLSLR | 91 | P26998 | |
| LSTWDRDTSDVNRQV | 2946 | Q8TDW7 | |
| SGSRDATLRVWDIET | 476 | Q969H0 | |
| RRADDTSGDRSIWTD | 211 | Q8IXQ4 | |
| SNRSLNATETSEAWD | 16 | P28221 | |
| WAEDKRDVDRSSSQS | 26 | Q7Z591 | |
| RDVDRSSSQSWEEER | 31 | Q7Z591 | |
| WQARRVHSDSETDDI | 471 | P78352 | |
| RSEASRILDEDSWSD | 136 | Q9H9L4 | |
| AQSRVEELAERLSWD | 131 | O15037 | |
| RDGSEASLEWSSERQ | 531 | P11047 | |
| VTGSDDRSVRLWSLA | 341 | Q6ZMW3 | |
| SSRSLQTLALETEWE | 241 | Q8N766 | |
| RERRDLFTESWDTQK | 281 | Q15762 | |
| FSWSDNERSSSRINI | 41 | Q5XKR9 | |
| FIWSTRRSAESEEVS | 826 | Q16478 | |
| WQSLEAKLRDSSDSE | 31 | A6NEL3 | |
| SSERARSFITWLRDS | 1206 | O95487 | |
| EATRDLDSELAERSW | 2211 | Q8TDX9 | |
| VIAALSRDTINRWSA | 276 | P08185 | |
| RRSWDSLNEDVETEV | 236 | Q8IY42 | |
| IVSRDWSNSSDRDSV | 1286 | Q5THK1 | |
| RDRNRDSDKTDTDWR | 186 | P23588 | |
| SWRSEETQERERSRT | 406 | P23588 | |
| GSDSVESARREIALW | 136 | Q13232 | |
| TTSRRDWKSDLSLER | 756 | Q9P2B2 | |
| TSRSSDELDAWTDFR | 296 | O43524 | |
| DELDAWTDFRSRTNS | 301 | O43524 | |
| RASSQDEAEDWLDRV | 606 | Q9Y4G2 | |
| AWRTKNSGSAEERSE | 26 | Q9GZV3 | |
| AWSADSRLLVSGSSD | 421 | Q9NVX2 | |
| AERNIALRSSLEWNS | 191 | Q7Z3J3 | |
| LESDKSDWRATNTDL | 221 | Q7Z3J3 | |
| DLDSLWEDFSQSLAR | 141 | Q8IYL2 | |
| QSATDTWENLVSDAR | 611 | Q6YHU6 | |
| TTDWQKDAERRDLTI | 141 | Q96Q11 | |
| SSISDRLVTLESWAN | 266 | Q96DX4 | |
| ENERRTTKAESAWLF | 521 | Q92581 | |
| RAAEQARWEAASKET | 396 | O60260 | |
| TLRSELSRIDSQWTD | 6876 | Q8NF91 | |
| ESDKSDWRATNTDLL | 221 | P0DJD1 | |
| TASVQWFERTLDDSA | 321 | P30566 | |
| SRSLIHSRAEQWADA | 1286 | Q9P2F8 | |
| LRRQRDSQEDWTTFT | 346 | O15357 | |
| DSQEDWTTFTHDRIR | 351 | O15357 | |
| NSRWDKRTLEQEDSS | 2656 | Q7Z333 | |
| SEWDLSTDAGERARL | 11 | Q9NVC3 | |
| EASRLWASRLTDDSM | 106 | Q96M29 | |
| NRATADIQRLLSWES | 131 | Q6ZUB0 | |
| WEAATEAASRADTIL | 251 | Q9NRC8 | |
| ECRDLSRTIIEWSES | 266 | Q92966 | |
| ERARSWSRGTQEQAS | 981 | Q9Y2I6 | |
| KDRSAEETFQLSRWT | 461 | O00186 | |
| SKAAASATREWTEQE | 591 | Q8TAQ2 | |
| TSNSSSVDWDTVERQ | 146 | Q9H2D6 | |
| QRSEERRKWFEATDS | 1981 | Q9H2D6 | |
| LVRESEAWEASLARS | 321 | P0CW24 | |
| EAWEASLARSVRAQT | 326 | P0CW24 | |
| AATWDERFSALERLT | 2066 | Q01082 | |
| RLEEDRQSLDLSSEW | 166 | Q9HCU9 | |
| DLESERTQRATERWL | 256 | Q96JN2 | |
| ENAASEDRWSSRQLS | 101 | Q9UNK9 | |
| EDRWSSRQLSDLRAA | 106 | Q9UNK9 | |
| SLRSAWDVITDSADF | 271 | Q9UQC9 | |
| RWREERFRQTSESTN | 186 | Q9BVK6 | |
| WTESSSDDLRNVTWR | 781 | Q9UHF7 | |
| NRATADIQRLLSWES | 131 | P0C874 | |
| SESELAARWEAEAVA | 96 | Q8NHH1 | |
| ALRQDRSWFRASNET | 91 | Q96MU6 | |
| SGSDDSRRWSDQLSL | 3326 | Q8IZQ1 | |
| WREDSLEFSLSDLSQ | 176 | Q13009 | |
| SDWDNDSSSARLFER | 31 | O15020 | |
| SATDAAIRVWSLQDR | 171 | Q12788 | |
| DTSWQALIDEDRLLS | 201 | Q14BN4 | |
| NWARSRDWEDVEESS | 1061 | Q5VZP5 | |
| ARSSVGWDATEDLRI | 376 | P42331 | |
| GWDATEDLRISRTDS | 381 | P42331 | |
| RSTSLDRDWAITFEQ | 1201 | Q6ZT07 | |
| ESSNDWNVEKRSIRD | 51 | Q93063 | |
| SSATERDEWLEAISR | 1166 | Q6ZV73 | |
| RVGSRTATSLDLEWD | 601 | Q92752 | |
| EEIRRSSQSWSLAAD | 26 | Q9Y4E1 | |
| LLQATEWASSEDTRR | 156 | Q9P283 | |
| GTRSLREALEAESAW | 3806 | Q15149 | |
| IWARESLARDTGLSE | 96 | O75360 | |
| AAWRLLDISASSTEQ | 436 | O43615 | |
| EEIRRSSQSWSLAAD | 26 | Q641Q2 | |
| DHTWDQESALRRNLS | 31 | Q6R2W3 | |
| REWAATETSSQQARS | 506 | Q8N5H7 | |
| DASTRDSADRTIIAW | 396 | Q64LD2 | |
| DSADRTIIAWDFRTS | 401 | Q64LD2 | |
| QTEELWSRTSSLFDI | 211 | Q9P2Z0 | |
| EVLSTTDRFTDNAWR | 1011 | Q9P2L0 | |
| DSLTHAVESWLDRRT | 221 | Q53S58 | |
| AVESWLDRRTASLSA | 226 | Q53S58 | |
| DWLARERLRTSTSDL | 1851 | Q5T5U3 | |
| EAISERSWQADSVDS | 806 | Q9ULE0 | |
| RLNSGSWSLTEDRDV | 76 | Q6AW86 | |
| NLWASRESVTSDGSR | 351 | Q6NSI3 | |
| DVRSAVALDWDSRDD | 771 | O75096 | |
| SSELSWEAQLRRQTS | 76 | Q5VTT5 | |
| QSSTSNRLWAEDSTE | 606 | O14974 |